Associations between Risk Perception, Smoking Behaviors, and Lung Cancer Screening in Smokers Receiving Inpatient Tobacco Treatment: A Prospective Study by Steed, Julia Martin
Associations between Risk Perception, Smoking Behaviors, and Lung Cancer Screening in  
Smokers Receiving Inpatient Tobacco Treatment: A Prospective Study 
 
 
By 
Julia Martin Steed 
 
Dissertation  
Submitted to the Faculty of the  
Graduate School of Vanderbilt University  
in partial fulfillment of the requirements  
for the degree of  
DOCTOR OF PHILOSOPHY  
in  
Nursing Science 
December 15, 2018 
Nashville, Tennessee  
 
Approved: 
Shelagh Mulvaney, PhD 
Ann Minnick, PhD 
Ken Wallston, PhD 
Hilary Tindle, MD 
  
ii 
 
ACKNOWLEDGMENTS 
 
 
 This work would not have been possible without the guidance and support of my dissertation 
committee from the Vanderbilt University School of Nursing (VUSN), Dr. Shelagh Mulvaney, Dr. Ann 
Minnick, and Dr. Ken Wallston. I am especially indebted to Dr. Hilary Tindle, Founding Director of the 
Vanderbilt Center of Tobacco, Addiction, and Lifestyle (ViTAL), who has mentored and allowed me to 
integrate my study under her direction with the Vanderbilt University Medical Center Tobacco Treatment 
Service.  
 I am grateful to all of those with whom I have had the pleasure to work during this project and to 
VUSN administrators who provided me with the protected academic time to achieve this goal. I would 
especially like to thank Dr. Linda Norman, Dr. Shelia Ridner, Dr. Mavis Schorn, Dr. Rolanda Johnson, 
Dr. Mariann Piano, Dr. Mary Dietrich, Dr. Courtney Pitts, and Dr. Betsy Kennedy. 
 Finally, I would like to thank the individuals in my life that have been most important to me in 
the pursuit of this project. I would like to thank my husband (Ronald) and daughter (Olivia), parents 
(Willie and Judy Martin), brother (William Martin), in-laws (Martin and Valerie Legger), and a host of 
other family and friends for providing a tremendous amount of encouragement and support throughout 
this journey. 
 
 
 
 
 
 
  
iii 
 
TABLE OF CONTENTS 
 
 
            Page 
ACKNOWLEDGEMENTS ··················································································  ii 
 
LIST OF TABLES  ····························································································  ix 
 
LIST OF FIGURES  ···························································································  xi 
 
LIST OF ABBREVIATIONS  ···············································································  xii 
 
Chapter 
I. INTRODUCTION ······················································································  1 
Scope of Problem  ················································································  1 
Purpose of the Study ··············································································   2 
Specific Aims and Hypotheses ··································································  3 
Aim 1 ························································································  4 
Aim 2  ························································································  4 
Hypothesis 2.1 ········································································  4 
Aim 3 ························································································  4 
Hypothesis 3.1 ········································································  4 
Hypothesis 3.2 ········································································  4 
Aim 4 ························································································  5 
Hypothesis 4.1 ········································································  5 
Significance of the Research ····································································  5 
 
II. LITERATURE REVIEW AND THEORETICAL FRAMEWORK ······························  6 
Introduction of Key Terms ······································································  6 
iv 
 
Review of the Literature ·········································································  7 
Prevalence of Cigarette Smoking and Effects of Tobacco Use ·······················  7 
Prevalence of Cigarette Smoking ··················································  7 
Health Effects of Cigarette Smoking ··············································   8 
Economic Effects of Cigarette Smoking ··········································  9 
Nicotine Addiction and Benefits of Cessation ··········································  9  
Nicotine Addiction  ········································································  9 
Benefits of Smoking Cessation ···························································  10 
Tobacco Treatment and Lung Cancer Screening ·······································  11 
Inpatient Tobacco Treatment ·······················································  11 
Low-Dose Computed Tomography (LDCT) Lung Cancer Screening ·········  12 
Relationships between Perceived Risk and Smoking ··································  13 
Risk Perception and Smoking Behaviors ·········································  13 
Risk Perception and Smoking Risk Factors ······································  14  
Synthesis of Theoretical Frameworks ··························································  15 
Perceived Risk and Outcome Expectancy ···············································  15 
Risk Perception and Health Behavior Theories ·········································  16 
The (modified) Model of Risk Information Seeking and Processing ················  16 
Summary of Findings ············································································  19 
 
III. METHODS ······························································································  21 
Study Overview ···················································································   21 
Research Design and Assumptions ·····························································  21 
Research Design ············································································  21 
v 
 
Design Assumptions ·······································································  22 
Description of the Research Setting ····························································  23 
Sample and Sampling Plan ······································································  24 
Power Analysis ·············································································  24 
Sampling Plan ········································································  25 
Study Sample ·········································································  25 
Criteria for Sample Selection ·····························································  26 
Inclusion Criteria ·····································································  26 
Exclusion Criteria ····································································  26 
Participant Recruitment and Informed Consent ···············································  26 
Participant Recruitment ····································································  26 
Informed Consent ··········································································  27 
Strategies to Ensure Human Subjects Protection ·······································  27 
Procedures and Data Collection ·································································  28 
Study Procedures ···········································································  28 
Procedures at Study Enrollment ····················································  29 
Procedures at Follow-Up ····························································  31 
Data Collection Time Points ······························································  31 
Survey Instruments for Independent Study Variables ·································  33 
Perceived Risk for Developing of a Smoking-Related Health Condition ·····  33 
Contextual Smoking Risk Factors ·················································  33 
Household Income ······················································  34 
Subjective Health Literacy ·············································  34 
Lifetime Smoking History (Pack Years) ·····························  35 
Nicotine Dependence ···················································  35 
Comorbid Smoking-Related Disease ·································  35 
Substance Abuse ························································  35 
Psychiatric Diagnosis ···················································  36 
vi 
 
Survey Instruments for Dependent Study Variables ···································  36 
Change in Perceived Risk ···························································  36 
Readiness to Quit Ladder (RTQ) ···················································  37 
Smoking Behavior Outcomes ······················································  38 
Smoking Status ···································································  38 
Quit Attempt at Three-Month Follow-Up ·····································  38 
Reduced Cigarette Consumption ················································  39 
Participation in Inpatient Tobacco Treatment  ···································  39 
Lung Cancer Screening via LDCT ·················································  39 
Pilot Testing ·······················································································  40 
Statistical Analyses ···············································································  41 
Data Reduction Techniques ·······························································  42 
Sociodemographic Variables ·······················································  42 
Smoking Risk Factors and Outcomes ·············································  42 
Management of Missing Data ·····························································  42 
Preliminary Analyses ······································································   43 
Analysis by Study Aim ····································································  43 
Statistical Analyses for Aim 1 ······················································  44 
Statistical Analyses for Aim 2 ······················································  44 
Statistical Analyses for Aim 3 ······················································  43 
Statistical Analyses for Aim 4 ······················································  45 
 
IV. RESULTS ································································································  46 
Introduction ························································································  46 
vii 
 
Characteristics of Hospitalized Smokers at Enrollment and Follow-up  ···················  46 
Bivariate Correlations between Perceived Risk and Smoking Risk Factors ···············  52 
Results Related to Aims ··········································································  54 
Results for Aim 1 ···········································································  54 
Results for Aim 2 ···········································································  55 
Results for Aim 3 ···········································································  56  
Smoking Status ·······································································  56 
Self-Reported Quit Attempt ························································  57 
Reduced Cigarette Consumption ···················································  59 
Participation in Inpatient Tobacco Treatment ····································  60 
Results for Aim 4 ···········································································  61  
 
V. DISCUSSION ···························································································  62 
Summary of Findings ············································································  62 
Characteristics of the Sample····································································  63 
Discussion of Results by Study Aim ···························································  64 
Aim 1: Change in Perceived Risk before and after Inpatient Tobacco Treatment ··  64 
Aim 2: Readiness to Quit (RTQ) at Study Enrollment ·································  64 
Aim 3: Smoking Behaviors at Three-Month Follow-up ·······························  65  
Smoking Status ·······································································  66 
Self-Reported Quit Attempt ························································  66 
Reduced Cigarette Consumption ···················································  66 
Participation in Inpatient Tobacco Treatment ····································  67 
Aim 4: Lung Cancer Screening via LDCT at Three-Month Follow-up ··············  67 
Implications for Research Methods and Design ··············································  68 
Implications for Clinical Practice ·······························································  70 
viii 
 
Limitations ·························································································  71 
Sample Attrition ············································································  71 
Data Collection ·············································································  71 
Statistical Analyses ·········································································  72 
Implications for Future Research ·······························································  72 
Conclusions and Next Steps ·····································································  75 
 
Appendix A. Additional Tables and Figures ·······························································  77 
Risk Perception Intervention Studies ······························································  77 
Comprehensive Correlation Matrix of All Study Variables ····································  80 
 
Appendix B. Vanderbilt University Medical Center Tobacco Treatment Service Care Processes ··  81 
VUMC TTS Care Protocol··········································································  81 
VUMC TTS Descriptions  ··········································································  82 
Vanderbilt University Medical Center’s Nurse Admission Form ······························  85 
VUMC TTS StarForm ···············································································  86 
 
Appendix C. Study Survey Instruments and Data Forms ·················································  91 
Post-TTS Enrollment Survey at the Bedside ·····················································  91 
 
REFERENCES  ································································································  96 
  
ix 
 
LIST OF TABLES 
 
 
Table            Page 
1. KEY CONCEPTS OF  
THE RISK INFORMATION SEEKING AND PROCESSING MODEL ····················  17 
 
2. SMOKING RISK FACTORS AND BEHAVIOR OUTCOMES  
EXAMINED ACROSS DATA COLLECTION TIME POINTS ······························  32 
 
3. CHARACTERISTICS OF HOSPITALIZED SMOKERS  
EXPOSED TO INPATIENT TOBACCO TREATMENT ······································  49 
 
4. PREVALENCE OF MEDICAL DIAGNOSES AMONG  
HOSPITALIZED SMOKERS EXPOSED TO INPATIENT TOBACCO TREATMENT ·  50 
 
5. SMOKING CHARACTERISTICS OF PARTICIPANTS  
AT ENROLLMENT (POST-TTS) AND THREE-MONTH FOLLOW-UP··················  51 
 
6. SIGNIFICANT BIVARIATE ASSOCIATIONS BETWEEN  
PERCEIVED RISK AND SMOKING RISK FACTORS AT STUDY ENROLLMENT ··  53 
 
7. SUMMARY STATISTICS OF RELIABLE CHANGE IN PERCEIVED RISK AMONG 
HOSPITALIZED SMOKERS - FROM PRE-TTS TO POST-TTS ····························  54 
 
8. ASSOCIATIONS BETWEEN READINESS TO QUIT  
AFTER INPATIENT TOBACCO TREATMENT AND 
PERCEIVED RISK WITH SMOKING RISK FACTORS ·····································  55 
 
9. MULTIPLE LINEAR REGRESSIONS BETWEEN READINESS TO QUIT AFTER 
INPATIENT TOBACCO TREATMENT AND PERCEIVED RISK (PRE-TTS) WITH 
SMOKING RISK FACTORS ······································································  56 
x 
 
 
10. UNIVARIATE LOGISTIC MODEL ESTIMATES  
OF PERCEIVED RISK AND SMOKING RISK FACTORS  
ON SMOKING STATUS AT THREE-MONTH FOLLOW-UP ······························  57 
 
11. UNIVARIATE LOGISTIC REGRESSIONS  
OF PERCEIVED RISK AND SMOKING RISK FACTORS  
ON SELF-REPORTED QUIT ATTEMPT AT THREE-MONTH FOLLOW-UP···········  58 
 
12. UNIVARIATE LOGISTIC MODEL ESTIMATES  
OF PERCEIVED RISK AND SMOKING RISK FACTORS  
ON SIGNIFICANT REDUCTION OF CIGARETTE CONSUMPTION  
AT THREE-MONTH FOLLOW-UP ······························································  60 
 
13. UNIVARIATE LOGISTIC MODEL ESTIMATES  
OF PERCEIVED RISK AND SMOKING RISK FACTORS  
ON PHARMACOLOGICAL PARTICIPATION AT THREE-MONTH FOLLOW-UP ···  61  
xi 
 
LIST OF FIGURES 
 
 
Figure            Page 
1. Model of Risk Information Seeking and Processing (RISP) ·······································  18  
 
2. Modified RISP Model (as an antecedent to preventive behavior) ·································  19 
 
3. Subject Recruitment and Study Design ·······························································  30 
 
4. Readiness to Quit Ladder (modeled after The Contemplation Ladder) ···························  38 
 
5. CONSORT Flow Diagram ·············································································  47 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
xii 
 
LIST OF ABBREVIATIONS 
 
 
AUDIT   Alcohol Use Disorders Test  
AUDIT-C  Alcohol Use Disorder Identification Test–Consumption  
CDC   Centers for Disease Control 
CMS   Centers for Medicare and Medicaid Services 
COPD   Chronic Obstructive Pulmonary Disease 
CPD   Cigarettes per day 
CHD   Coronary Heart Disease 
CVD   Cardiovascular Disease 
IOM   Institute of Medicine 
JCAHO   Joint Commission on the Accreditation of Healthcare Organizations 
LDCT   Low-Dose Computed Tomography  
MI   Myocardial Infarction 
NLST   The National Lung Screening Trial 
Pre-TTS  (Pre) Before exposure to Tobacco Treatment Services 
Post-TTS  (Post) After exposure to Tobacco Treatment Services 
RTQ   Readiness to Quit Ladder 
SRD   Smoking-related disease 
TTFC   Time to first cigarette 
TTS   Tobacco Treatment Service 
WHO   World Health Organization 
VUMC   Vanderbilt University Medical Center  
xiii 
 
USDHHS   United States Department of Health and Human Services 
USPHS   United States Public Health Service 
 1 
 
CHAPTER I 
 
 
Introduction 
 
 
Scope of the Problem 
 
Tobacco use is the leading cause of preventable death in the United States, and standard cigarettes 
are the most commonly consumed type of tobacco (United States Department of Health and Human 
Services [USDHHS], 2014). Smoking-related health conditions are a major cause of morbidity and 
mortality (USDHHS, 2014). Smoking, in any form, harms nearly every organ in the body and is linked to 
an estimated 90% of carcinomas affecting the trachea, bronchus, and lungs (American Cancer Society, 
2015; Centers for Disease Control and Prevention (CDC), 2015a; CDC, 2015b; CDC, 2016; National 
Institute of Drug Abuse [NIDA], 2012). Lung cancer is the second most common type of cancer and the 
leading cause of cancer-related death in the United States, accounting for almost 25% of all cancer-related 
deaths (American Cancer Society, 2017).  
Despite scientific evidence validating the serious health consequences of smoking cigarettes, 
most people do not accurately perceive the extent to which smoking increases the probability of adverse 
health outcomes (Boney-McCoy et al., 1992; CDC, 2007; Krosnick et al., 2017). Although the number of 
cigarettes consumed per smoker has decreased over time, a smoker’s risk of developing a smoking-related 
disease or lung cancer has continually increased, when compared to the overall risk of lung cancer in the 
U.S. (USDHHS, 2014). In fact, cigarette smokers are 15 to 30 times more likely to be diagnosed or die 
from lung cancer than people who do not smoke (USDHHS, 2014). Unfortunately, most smokers do not 
understand or choose to ignore the severity of lung cancer or other health conditions attributable to 
smoking (Ayanian & Cleary, 1999; Cummings et al., 2004; Gallup Organization, 2014; Rutten et al., 
2008; Weinstein, Slovic, Waters, & Gibson, 2004). 
Smokers that have developed adverse medical conditions are at an increased risk for developing 
disabling health problems. Medical care for this unique population of smokers contributes to added costs 
for health care and these costs are estimated to exceed more than $300 billion each year in lost 
productivity and direct medical care (CDC, 2016; Fiore & Gopelrud, 2012; USDHHS, 2014; Xu et al., 
2016). More than 16 million American smokers are confronted with the diagnosis of a smoking-related 
cardiopulmonary disease, including four of the eight leading causes of death worldwide: 1) ischemic heart 
disease, 2) cerebrovascular disease, 3) lower respiratory infections, and 4) chronic obstructive pulmonary 
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disease (CDC, 2016). Lung cancer is prevalent among smokers in the United States as well, with 222,500 
new cases reported in 2014 (American Cancer Society, 2017). Because smokers do not typically take 
advantage of available tobacco treatment resources (WHO, 2011), national clinical guidelines were 
developed to guide practitioners in smoking cessation strategies and some of these include assessing 
motivation to quit, and advising cessation at every primary care medical encounter (Larzelere & 
Williams, 2012; Radziewicz et al., 2009; Song et al., 2009). 
Hospitalization offers an optimal environment to deliver evidence-based treatment for tobacco 
dependence and serves as venue to facilitate smoking cessation and coordinate lung cancer screening 
services (American Cancer Society, 2015; Fiore et al., 2008; Fiore & Gopelrud, 2012; Rigotti et al., 2014; 
Tanni et al., 2009; USDHHS, 2014). Hospitals accredited by the Joint Commission on the Accreditation 
of Healthcare Organizations (JCAHO) mandate patient smokers to temporarily abstain from cigarette 
smoking inside of the facility and around the surrounding premises (Centers for Medicaid and Medicaid 
Services [CMS], 2015; Fiore & Gopelrud, 2012; JCAHO, 2015; Regan, Viana, Reyen, & Rigotti, 2012; 
Ylioja et al., 2017). Once admitted into the hospital, smokers are subjected to tobacco screening questions 
and an “opt out” discussion regarding treatment interventions that support smoking cessation (CMSa, 
2015). Additional clinical practice guidelines recommend coordinated hospital services to refer older, 
high-risk smokers to undergo advanced lung cancer screening via low-dose computed tomography 
(LDCT) to detect early signs of lung cancer (Blackmon & Feinglass, 2015; CMSb, 2015; Fiore et al., 
2008; Gillaspie & Allen, 2015; The National Lung Screening Trial [NLST], 2011). LDCT imaging is 
more effective than conventional screening methods for early identification and has been proven to reduce 
the incidence of lung cancer mortality by 20% (NLST, 2011). 
 
 
Purpose of the Study 
 
Some past studies have produced inconsistent results when testing whether smokers accurately 
estimate their own actual health risk of experiencing smoking-related illness (Weinstein, Marcus & 
Moser, 2004). However, general consensus indicates that smokers may discount the increased risk they 
face from continued smoking and do not view themselves at risk of heart disease or cancer (Ayanian & 
Cleary, 1999; Weinstein, 2004). In addition, a smoker’s perception of health risks has been shown to 
predict several smoking behavior variables (e.g., a desire to quit, smoking cessation) among ambulatory 
smokers (Institute of Medicine [IOM], 2012; Sone et al., 2009; United States Public Health Service 
[USPHS], 2014). Evidence also indicates that perceived risk influences compliance with 
recommendations to complete lung cancer screening via LDCT in outpatient settings (Borelli et al., 2010; 
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Carere et al., 2015; IOM, 2012; Park et al., 2013; Waters, McQueen, & Cameron, 2014). Perceptions of 
smoking-related health risks refer to subjective judgments about the probability of the occurrence of 
negative outcomes. Although there is literature on how a smoker’s perceived risk impacts smoking 
behaviors and related outcomes, the perceived risk of hospitalized smokers has been less well studied.  
Inpatient tobacco treatment programs offer an opportunity to provide smokers with an objective 
estimate of risk for developing a smoking-related health condition and advice about quitting (Reid et al., 
2015). In addition, the delivery of tobacco treatment interventions in a hospital setting may encourage the 
smoker to quit or reduced smoking frequency in an effort to enhance medical recovery (Krosnick et al, 
2006; Reid et al., 2015). Others have reported that if an individual has a higher perceived risk of 
developing a negative health outcome at one point in time, they are more likely to engage in future health-
protective behaviors (Janssen et al., 2011; Waters, McQueen, & Cameron, 2014). However, perceived 
risk in smokers is a complex concept and is dependent upon multiple contextual risk factors (American 
Cancer Society, 2015; Brewer et al., 2004; Scientific Standards for Studies on Modified Risk Tobacco 
Products, 2012; Waters, McQueen, & Cameron, 2014).  
The purpose of this study was to evaluate a smoker’s change in perceived risk for developing a 
smoking-related health condition before (pre-TTS) and after (post-TTS) exposure to an inpatient tobacco 
treatment program and examine the influence of perceived risk, in the context of smoking risk factors, on 
subsequent smoking-behavior outcomes. The study was conducted at Vanderbilt University Medical 
Center (VUMC). VUMC has implemented the national clinical guidelines and JCAHO standards, which 
mandate tobacco screening and inpatient tobacco treatment services for all hospitalized current smokers. 
The Vanderbilt University Medical Center (VUMC) Tobacco Treatment Service (TTS) program was 
created to provide a brief, inpatient tobacco treatment intervention for all self-identified, adult (>18 years) 
cigarette smokers admitted for an inpatient hospital stay. The VUMC TTS employs Certified Tobacco 
Treatment Specialists (CTTS) who visit each hospitalized smoker at the bedside for an “opt-out” 
consultation and perform evidence-based standard-of-care treatment for tobacco dependence. 
 
 
Specific Aims and Hypotheses 
 
Study aims were accomplished by using a descriptive and correlational research design to explore 
change in perceived risk and identify covariate factors that may moderate the relationship between 
perceived risk and a variety of smoking behaviors among hospitalized smokers. The following aims 
describe the specific study goals: 
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Aim 1  
Identify the extent and nature of change (from before inpatient tobacco treatment [pre-TTS] to 
after inpatient tobacco treatment [post-TTS]) in perceived risk of smoking-related health condition among 
hospitalized smokers exposed to a brief, inpatient tobacco treatment program.  
 
  
Aim 2  
Evaluate the influence of perceived risk of smoking-related health condition, in the context of 
smoking risk factors, on readiness to quit smoking among hospitalized smokers exposed to a brief, 
inpatient tobacco treatment program.  
 Hypothesis 2.1. Perceived risk pre-TTS, in the context of smoking risk factors, will influence 
readiness to quit smoking, as evidenced by the individual’s subjective desire to quit smoking as assessed 
by a contemplation ladder at study enrollment.  
 
 
Aim 3  
Determine relationships between perceived risk of smoking-related health condition, in the 
context of smoking risk factors, and subsequent smoking behavior outcomes among hospitalized smokers 
exposed to a brief, inpatient tobacco treatment program. 
 Hypothesis 3.1. The higher the perceived risk (pre-TTS) for developing smoking-related health 
condition in the context of smoking risk factors at study enrollment, the greater the likelihood of positive 
smoking behavior outcomes at the three-month follow-up: 1) non-smoking status (defined as self-
reported, 30-day point prevalence abstinence), 2) self-report of a an attempt to quit smoking (defined as 
whether or not the smoker abstained from smoking cigarettes for greater than one day because they were 
trying to quit between study enrollment and follow-up), and 3) significant reduction in cigarette 
consumption (defined as > 50% reduction in the number of cigarettes smoked per day at follow-up 
relative to cigarettes per day self-reported at study enrollment). 
 Hypothesis 3.2. The higher the perceived risk (pre-TTS) for developing smoking-related health 
condition, in the context of smoking risk factors at study enrollment, the greater the likelihood smokers 
will self-report participation in evidence-based inpatient TTS modalities, including 1) acceptance of the 
recommendation followed by subsequent use of pharmacologic tobacco treatment and 2) acceptance of 
the referral followed by subsequent involvement in behavioral tobacco treatment via the state tobacco quit 
line). 
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Aim 4  
Determine the relationship between perceived risk of smoking-related health condition, in the 
context of smoking risk factors, and completion of lung cancer screening imaging via LDCT among 
older, high-risk, hospitalized smokers exposed to a brief, inpatient tobacco treatment program. 
 Hypothesis 4.1. The higher the perceived risk (post-TTS) for developing smoking-related health 
condition, in the context of smoking risk factors at study enrollment, the greater the likelihood that 
imaging for lung cancer screening via LDCT will be completed among eligible, high-risk smokers 
(acceptance of the referral for lung cancer screening followed by having the scan completed) at the three-
month follow-up. 
 
 
Significance of the Research 
 
Perceived risk is a concept included in many health behavior models and has been used to inform 
the development and evaluation of tobacco treatment programs in both ambulatory and inpatient settings 
(Faseru et al., 2011; Janz & Becker, 1984; PHS, 2008; Reid et al., 2015; Rigotti et al., 2014; Rigotti, 
Munafo, & Stead, 2008; Rogers & Prentice-Dunn, 1997; Weinstein, 1988). Findings from tobacco 
intervention studies indicate that a smoker’s perceptions of risks, benefits, and expectancies associated 
with cigarette smoking can predict smoking behaviors, sustain abstinence after discharge, and promote 
cancer screening (McQueen, Swank, Bastian, & Vernon, 2008; Radziewicz et al., 2009; Song et al., 
2009). However, no studies, to date, have investigated the direct influence of health risk perceptions on 
smoking behavior variables or preventive lung cancer screening via LDCT among inpatient smokers. 
In conclusion, smokers are at an increased risk for developing significant health burdens 
associated with development or progression of smoking-related cardiopulmonary disease and lung cancer. 
An inpatient hospital stay remains a relatively unexplored setting to deliver treatment interventions for 
tobacco dependence and coordinate lung cancer screening services for older, high-risk smokers 
(American Cancer Society, 2015; Tanni et al., 2009; USDHHS, 2014). This study will generate new 
knowledge in tobacco research related to the effects of inpatient tobacco treatment on health risk 
perceptions of smoking and the influence of perceived risk on short-term smoking behavior variables and 
lung cancer screening after hospital discharge. The study will also inform the care process of the VUMC 
TTS program by providing data about their patients’ smoking status and report of participation in various 
aspects of the inpatient tobacco treatment program. 
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Chapter II 
 
 
Literature Review and Theoretical Framework 
 
 
The purpose of this chapter is to: 1) describe the health and economic implications related to  
cigarette smoking; 2) elucidate the influence of perceived risk for developing smoking-related health 
condition on smoking behavior and lung cancer screening outcomes; 3) provide a brief overview of 
theoretical approaches used to investigate perceived risk in relation to health behaviors and tobacco use; 
and 4) demonstrate how a conceptual model that synthesizes health communication and preventive 
behaviors is representative of relationships between study variables. Several terms are defined at the 
outset and these include: ‘perceived risk’/‘health risk perception’ associated with optimistic bias, 
‘smoking status’/‘smoker’, and ‘hospitalization’/ ‘inpatient status’.  
 
 
Introduction of Key Terms 
 
Perceived risk is a central construct among health behavior theories that describes an individual’s 
beliefs about the potential harms of an event or how they understand and experience a situation that may 
be hazardous to their health (Brewer et al., 2007; Oltedal, Moen, Klempe, & Rundmo, 2004). The term 
perceived risk represents a variety of analogous constructs known to influence human behavior that may 
be labeled as risk perception, perceived susceptibility, perceived vulnerability, perceived likelihood, or 
feelings of risk (Waters, McQueen, & Cameron, 2014). Risk can be perceived from either an individual 
viewpoint or in comparison to others. Personal risk describes how likely the individual is to 
independently experience a hazardous event. Comparative risk describes how likely a person is to 
experience a hazardous event compared to another person that shares similar characteristics (Waters, 
McQueen, & Cameron, 2014). Generally, individuals tend to believe that other people have a greater 
chance of experiencing a negative event than themselves and will disregard the base rate of an event 
occurrence (Klein & Stefanek, 2007; Oltedal et al., 2004). Conversely, actual risk is the objective 
likelihood of experiencing a hazardous health outcome over a specific time period and calculated from 
statistics and probability distributions (Oltedal, Moen, Klempe, & Rundmo, 2004; Waters, McQueen, & 
Cameron, 2014). 
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Smokers typically underestimate their relative risk to develop negative health consequences 
compared to non-smokers and often believe they have a lower risk of developing lung cancer than the 
average smoker (Ayanian & Cleary, 1999; Dillard & Klein, 2006; Weinstein, Marcus, & Moser, 2005). 
This optimistic bias in such comparative risk judgments remains even when the smoker has historically 
smoked heavily throughout their lifetime (Weinstein, 1998). Current and former smokers are also known 
to mistakenly believe myths that exercise can reverse most of the effects of smoking and that lung cancer 
is determined primarily by genes (Weinstein, Marcus, & Moser, 2005). In addition, smokers claim that, 
compared to the average smoker, they smoke fewer cigarettes per day, smoke cigarettes with toxins and 
nicotine content, inhale less deeply, are less addicted, and have a healthier lifestyle (Segerstrom, 
McCarthy, & Caskey, 1993; Weinstein, Marcus, & Moser, 2005). They also greatly overestimate the 
likelihood that their next quit attempt will be successful (Weinstein, 2004). 
In this study, active smoking status is defined as self-reports current or recent exposure to inhaled 
nicotine from tobacco through a cigarette within the past month (30-day point prevalence). This definition 
applies to both daily and non-daily cigarette smokers but excludes other tobacco products such as cigars 
and pipes, and smokeless tobacco products in which nicotine is absorbed in the oral or nasal cavity, such 
as spit tobacco or snuff (WHO, 2017). This definition also excludes inhaling nicotine from an electronic 
nicotine device system, commonly referred to as e-cigarettes or vapors. Lastly, the terms hospitalization 
or inpatient status, refer to the admission of a patient into the hospital for a minimum of one overnight 
stay to undergo treatment that requires surveillance by medical professionals (Medicare.gov, n.d.). The 
definition of this term excludes emergency room admissions or same day surgery/procedure admissions. 
 
 
Review of the Literature 
 
 
Prevalence of Cigarette Smoking and Effects of Tobacco Use 
 
Prevalence of Cigarette Smoking. Approximately 15% of the adult population in the United 
States are daily smokers (CDC, 2015; Jamal et al., 2016). Smoking prevalence is typically assessed by 
frequency of cigarette consumption, or the number of cigarettes smoked per day (CPD). Certain 
sociodemographic variables are associated with CPD. For example, CPD are greater for men (18 to 64 
years), certain racial/ethnic groups (e.g., American Indian), minority groups, the unemployed, and those 
with less than high school education. Cigarette smoking rates are also greater within households with a 
combined incomed below the poverty threshold and in individuals with co-existing mental health 
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illnesses, alcoholism, or other substance abuse issues (CDC, 2015b; CDC, 2016; Lasser et al., 2000; Terry 
et al., 2017).  
Health Effects of Cigarette Smoking. Cigarette smoking harms nearly every organ in the body 
and is a major risk factor for many chronic conditions. Smoking increases the risk of developing Type 2 
diabetes, age-related macular degeneration, blindness, cataracts, hip fractures, rheumatoid arthritis, 
impaired immune function, periodontitis, and overall diminished health (USDHHS, 2014). Smoking is 
known to slow bone and wound healing, which may interfere with medical recovery from trauma or 
breakdown (Fiore et al., 2008). Smoking is also linked to other cancer diagnoses, such as acute myeloid 
leukemia and dysplasia that develops in the head, neck, esophagus, stomach, liver, pancreas, kidney, 
ureter, cervix, bladder, colon, and rectum (USDHHS, 2014).  
More than 16 million Americans live with a smoking-related cardiopulmonary disease (CDC, 
2016). Coronary heart disease (CHD) is the leading cause of death in the United States, killing more than 
800,000 people a year (CDC, 2014). Cigarette smoking is a major risk factor for CHD by causing 
progressive narrowing of blood vessels leading to the heart (CDC, 2014; USDHHS, 2014). Other 
cardiovascular smoking-related diseases include peripheral arterial disease, stroke, myocardial infarction, 
and abdominal aortic aneurysm (USDHHS, 2014). Almost 8 million Americans have had a myocardial 
infarction (MI) and 7 million have had a stroke (CDC, 2017). But, people who continue to smoke after a 
MI or stroke are more likely to experience a second event and subsequent death (Fiore et al., 2008). The 
third leading cause of death in the United States is chronic obstructive pulmonary disease (COPD), which 
is an inflammatory lung disease that includes chronic bronchitis and emphysema (CDC, 2017; USDHHS, 
2014). Among 15 million U.S. adults with COPD, 39% continue to smoke (CDC, 2011). Additional 
smoking-related pulmonary conditions, include asthma and pneumonia (USDHHS, 2014).  
Cigarette smoking is the leading risk factor for lung cancer. Lung cancer is the leading cause of 
cancer-related death in the United States, accounting for almost 25% of all cancer deaths (American 
Cancer Society, 2017; CDC, 2014; CDC, 2017). Common symptoms experienced with a diagnosis of 
lung cancer are persistent cough, pleuritic chest pain, hoarseness, sputum streaked with blood, reoccurring 
bronchitis or pneumonia, a new onset of wheezing, weight loss and anorexia, worsening shortness of 
breath, lethargy, and weakness (American Cancer Society, 2015; American Cancer Society, 2017; Little, 
Gay, Gaspar, & Stewart, 2007; Molina et al., 2008). Approximately 90% of people diagnosed with lung 
cancer will ultimately die of the disease, but some do survive with early detection and effective treatment 
(Fiore et al., 2008; Moyer, 2014). Persons with lung cancer that continue to smoke place themselves at an 
elevated risk for developing a reoccurrence of cancer in a similar region (Fiore et al., 2008).  
Tobacco use has caused the death of 100 million people worldwide in the 20th century (WHO, 
2011). The annual death toll of cigarette and other tobacco use in the United States is approximately 
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400,000 to 500,000 deaths, and lung cancer is responsible for approximately half of those deaths 
(~155,000) (American Cancer Society, 2017; CDC, 2014; cdc.gov, updated May 31, 2017; USDHHS, 
2014). Unfortunately, the mortality rate of cardiopulmonary smoking-related disease far exceeds the 
number of lung cancer deaths each year along with a combined total of all deaths attributed to alcohol, 
homicide, illicit drug use, suicide, and AIDS (CDC, 2016; CDC.gov, updated May 31, 2017; Giovino et 
al., 2009; IOM, 2007; NIDA, 2012; USDHHS, 2014). These health-related effects of cigarette smoking 
and nicotine dependence generate significant costs to the individual consumer and society. 
Economic Effects of Cigarette Smoking. Of the $3 trillion of federal debt in the United States, 
health care expenditures attributable to cigarette use account for at least 20% of this federal debt (Kaiser 
Family Foundation, 2012; USPHS, 2014). Annual expenses specifically caused by smoking-related 
morbidity and mortality each year can equal at least $156 billion and up to $170 billion (CMS, 2015; 
Terry et al., 2017). Finally, an additional $6 billion in health care expenditures each year are related to 
second-hand cigarette smoke exposure (USDHHS, 2014). The financial burden associated with cigarette 
smoking is intensified by health care expenditures of more than $289 billion from lost work productivity, 
workplace absenteeism, shortened work lives, disability, missed opportunities for prevention of smoking-
related diseases, and premature death (IOM, 2007; USDHHS, 2012). Unfortunately, taxpayers are held 
responsible to pay for the enormous amount of health care debt related to smoking-related health 
condition (USDHHS, 2014). 
 
 
Nicotine Addiction and Benefits of Smoking Cessation 
 
Nicotine Addiction. Smoking cessation is difficult for many individuals, because cigarette 
smoking is associated with the rapid delivery (10-60 seconds of inhalation) of nicotine to the brain which 
promotes cycle of nicotine addiction (Benowitz, 1996). Nicotine is a highly addictive compound which 
stimulates the release of the neurotransmitter dopamine, creating the transient feeling of pleasure and 
calmness (Benowitz, 2010). However, smoking cessation can significantly reduce a smoker’s existing risk 
of short- and long-term health problems associated with the development of smoking-related 
cardiopulmonary disease and lung cancer (Godtfredsen et al., 2008; Peto et al., 2000; U.S. Preventive 
Services Task Force [USPSTF], 2013). Although variable among individuals, cigarette smokers become 
quickly addicted to nicotine (Benowitz, 2010; Danni & Harris, 2005). For example, with brief periods of 
smoking cessation (e.g., several hours) a smoker may experience nicotine withdrawal symptoms such as 
feelings of irritability, strong cravings or urges to smoke, depression/anxiety, cognitive/attention deficits, 
sleep disturbances, and increased appetite (Hendricks et al., 2006; National Institute for Drug Addiction 
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[NIDA], 2012). With long-term tobacco use, a smoker’s brain experiences an upregulation of nicotinic-
acetylcholine receptors, which causes the brain to require increasing amounts of nicotine to operate 
normally and avoid experiencing withdrawal (Benowitz, 2010; Danni & Harris, 2005). As a result, 
smokers develop compulsive drug seeking behaviors and continue to smoke despite negative health 
consequences (NIDA, 2012).   
Benefits of Smoking Cessation. Of the 60 million daily smokers in the United States, most will 
acknowledge the harmful effects of tobacco; and more than half may express a desire to quit (NIDA, 
2012). Unfortunately, 85% of smokers who try to stop smoking without tobacco cessation treatment 
interventions, relapse as quickly as within the first week (NIDA, 2012). Evidence-based, population-level 
tobacco treatment interventions/guidelines include methods for tobacco screening and assessment, along 
with recommendations to provide FDA-approved prescription and over-the-counter medications, offer 
behavioral counseling via state tobacco quit lines, and disseminate anti-smoking mass media messages 
(Terry et al., 2017). Nicotine replacement medications which are available in different formulations (e.g., 
gum, patches, and inhalers) can alleviate the physical withdrawal effects of nicotine, but cravings still 
often persist (NIDA, 2012). This gap in treatment is filled by applying behavioral therapy to help smokers 
identify triggers and implement coping strategies to manage nicotine withdrawal (NIDA, 2012). With the 
support of pharmacological treatment, 11 to 20% of smokers can remain abstinent for at least six months 
(Sutherland, 2003). Even healthy smokers can also experience a modest reduction in cardiovascular risk if 
they are able to reduce their level of nicotine dependence by smoking at least 50% less cigarettes per day 
(Hatsukami et al., 2005; Mooney, Johnson, Breslau, Beirut, & Hatsukami, 2011). 
There are many sociodemographic, behavioral, environmental, and health-related variables 
related to smoking behaviors and health outcomes. However, the most widely accepted predictors of 
abstinence failure are the presence of a smoking-related disease, advanced age, less desire or readiness to 
quit, time to first cigarette (TTFC) within 5 minutes of waking in the morning, an indication of greater 
nicotine dependence and, overall diminished health (Lando, Hennrikus, McCarty, & Vessey, 2003; 
USDHHS, 2014). When compared to non-smokers, current and former smokers often report fewer 
preventive outpatient medical visits, thus increasing their risk for developing a smoking-related disease 
and the likelihood of requiring a hospital admission to treat conditions that have progressed to an 
advanced state (USDHHS, 2014). These findings further support the connection between nicotine 
dependence, health status, tobacco treatment, and smoking behaviors. 
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Tobacco Treatment and Lung Cancer Screening 
 
Inpatient Tobacco Treatment. A hospitalization is a unique opportunity to implement tobacco 
treatment interventions and preventive screening activities among adult smokers. This is because: 1) A 
smoking-related health condition is the leading cause of hospitalizations in the United States (Fiore & 
Gopelrud, 2012; WHO, 2011); 2) A hospitalization may represent a vulnerable health state, in which the 
smoker may be more likely to appreciate a connection between their poor health and short-term risk 
perception (Becker & Janz, 1987); 3) Hospitalized smokers are in constant contact with health 
professionals during their inpatient stay and may be more willing to accept expert advice about quitting 
(CMSa, 2015; Johnson et al., 1999; Regan et al., 2012); 4) Hospitalized smokers must temporarily abstain 
from smoking due to JCAHO safety regulations (JCAHO, 2015); 5) Hospitalized smokers are a captive 
audience to receive evidenced-based tobacco treatment from a tobacco treatment expert and learn how 
smoking affects their health risk (Fiore & Gopelrud, 2012; France, Glasgow, & Marcus, 2001; Rigotti et 
al., 2012; Ylioja et al., 2017); and 6) During their forced abstinence, inpatient smokers may receive 
nicotine replacement and other therapies to mitigate nicotine withdrawal symptoms which may motivate 
smokers to maintain cessation after hospital discharge  (Fiore & Gopelrud, 2012; France, Glasgow, & 
Marcus, 2001; Rigotti et al., 2012; Rigotti et al., 2014; Ylioja et al., 2017).  
There are evidence-based guidelines for cessation of tobacco use in hospitalized smokers. Current 
guidelines were developed using data from clinical trials and modeled by the Ottawa Model for Smoking 
Cessation (OMSC) (Mullen, 2017; Rigotti et al., 2012; Fiore et al., 2008). The OMSC model includes 
specific evidence-based interventions in all hospitalized smokers and as noted above includes identifying 
and documenting smoking status, providing a brief counseling session and in-hospital pharmacotherapy to 
smokers, and offering follow-up support post-hospitalization (Mullen et al., 2017; Reid et al., 2010; Reid, 
Pipe, & Quinlan, 2006). Previous studies investigating the OMSC provide evidence that simple, 
systematic support to smoking cessation within a health care setting can lead to a significant increase in 
quit attempts and improve long-term cessation by an absolute 11% (from 18% to 29%) among 
hospitalized patients who smoke (Reid et al., 2010).   
Others have examined the effectiveness of implementing the Joint Commission's standards at 
several large medical institutions in the U.S. (Fiore et al., 2008; Fiore et al., 2012; National Quality 
Forum [NQF], 2014; Rigotti et al., 2012; Rigotti et al., 2014). Active participation with inpatient tobacco 
treatment interventions can significantly reduce a smoker’s risk of developing a smoking-related health 
condition and improve outcomes for smokers already living with a related heart or lung condition, 
regardless of the smoker’s initial interest in receiving treatment (CMSa, 2015; Rigotti, Munafo, & Stead, 
2008). In addition, smokers who successfully abstain for the duration of their hospital stay may 
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experience an increase in self-efficacy regarding quitting, which greatly improves their odds of 
experiencing a successful long-term behavior change (Duffy, Scholten, & Karvonen-Gutierrez, 2010; 
Rigotti, Munafo, Murphy, & Stead, 2001; Shmueli, Fletcher, Hall, Hall, & Prochaska, 2008). Research 
findings suggest that inpatient interventions for tobacco dependence are more likely to produce significant 
results when a follow-up assessment is completed one week to six months after hospital discharge by a 
quit line counselor or quit coach, automated voice response telephone call, or home visit (Faseru et al., 
2011; France, Glasgow, & Marcus, 2001; Reid et al., 2015; Rigotti et al., 2015).  
Low-Dose Computed Tomography (LDCT) Lung Cancer Screening. A critical factor to 
determine an individual’s actual risk for developing lung cancer is cumulative exposure, which considers 
one’s age, frequency of tobacco consumption (CPD), and duration of smoking (number of years since 
smoking initiation) (American Cancer Society, 2015; USDHHS, 2014). The incidence of a lung cancer 
diagnosis attributable to cumulative cigarette exposure has been verified in a multivariate model. 
Modeling demonstrates that current smokers 55 years and older are within the highest (60%) risk category 
and account for 88% of all preventable lung cancer deaths (Moyer, 2014; USPSTF, 2013). Fortunately, 
high-risk smokers who quit experience a reduction in lung cancer risk that continues to decline as the 
duration of time since smoking cessation is extended (Tindle et al., 2018). Other significant risk factors 
for lung cancer include: personal or family history of malignancy; radiation of the chest; diagnoses of 
COPD, pulmonary fibrosis, or pneumonia; and occupational or environmental exposure (American 
Cancer Society, 2017; CDC, 2014; Shepshelovich et al., 2015; USDHHS, 2014; USPSTF, 2013). 
Occupational exposure is likely in industries involved in paving, rubber, roofing, painting, and chimney 
sweeping. Environmental risks are associated with exposure to secondhand tobacco smoke, asbestos, 
radon gas released from soil and buildings, air pollution, diesel exhaust, and certain metals (USDHHS, 
2014). 
Most cases of lung cancer are discovered after the disease has advanced to a point where curative 
treatment is not possible (American Cancer Society, 2015; American Cancer Society, 2017; CDC, 2015a; 
Manser et al., 2013). Individuals diagnosed with late-staged lung cancer are potentially disadvantaged 
with a 5-year survival rate of 4% to 17% compared to an overall 5-year survival rate of 15% for men and 
21% for women who do not have lung cancer (American Cancer Society, 2015; American Cancer 
Society, 2017, Moyer, 2014; Shepshelovich et al., 2015; USPSTF, 2013). It is evident that long-term 
smokers, diagnosed with chronic bronchitis or emphysema, are more likely to delay seeking medical 
evaluation of symptoms that suggest lung cancer due to a combination of individual and psychosocial 
factors and failure to recognize the seriousness of their symptoms (Smith, Pope, & Botha, 2005). 
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Relationships between Perceived Risk and Smoking 
 
Tobacco literature has established that the perception of risk for developing a smoking-related 
cardiopulmonary disease does influence smoking behaviors and lung cancer screening among current, 
adult smokers. Perceived risk, in the context of cigarette use, represents a smoker’s beliefs about potential 
harms of hazardous smoking effects to their health (Brewer et al., 2007; Oltedal, Moen, Klempe, & 
Rundmo, 2004). Although smokers often fail to acknowledge the impact of smoking on quality of life, 
health behavior theories support that higher levels of perceived risk can encourage smokers to take action 
to improve overall health and reduce their overall actual risk for developing a smoking-related health 
condition (Gibbons, McGover, & Lando, 1991; Montes et al., 2007; Onken et al., 2005; Waters, 
McQueen, & Cameron, 2014). Data from longitudinal studies found that perceived risk and smoking 
abstinence are positively associated (IOM, 2012; USPHS, 2014). Data from cross-sectional studies also 
indicate that smokers reporting higher levels of perceived risk are more worried about developing lung 
cancer and more likely to adhere to recommendations for screening procedures in order to prevent death 
(p<0.05) (Montes et al., 2007).  
Risk Perception and Smoking Behaviors. To assess the findings related to perceived risk and 
smoking behaviors in previous tobacco intervention studies, a literature review was conducted focusing 
on twelve (12) studies, based on an inclusion criterion that risk perception was a predictor or outcome 
variable of a smoking behavior (e.g., smoking status, smoking cessation, motivation to quit, quit attempts, 
CPD, TTFC, cutting back, etc.). Among the included studies, perception of health risks related to 
smoking was examined at baseline, prior to implementation of an intervention only, immediately after 
implementation of an intervention only, or at both time points before and after an intervention. The study 
outcomes identified included change in perceived risk, lung cancer screening via LDCT, and a variety of 
smoking behaviors.  
Relevant findings indicate a variation in baseline levels of smoking-related perceived risk among 
groups of smokers and identified specific variables that influence a change in perceived risk over time 
(Appendix A). Seven prospective studies were examined that specifically evaluated longitudinal change 
in perceived risk. These studies were evaluated to predict the direction of change in perceived risk 
experienced as a result of a tobacco-related intervention. Unfortunately, baseline perceived risk levels 
reported among these studies may have been biased due to the inclusion of non-smoking participants 
(Carere et al., 2015; Persky et al., 2010). Randomized controlled trials, not included in this review, have 
reported measures of perceived risk among hospitalized smokers, but risk perceptions were not the 
primary outcome variable nor was risk perception included as a modifying variable of smoking behavior 
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(Rigotti et al., 2014; Rigotti et al., 2016). None of the studies included in this review explored 
hospitalized smokers, but one study did present data to evaluate perceived risk among medically ill 
patients in an outpatient setting (Borelli et al., 2010).  
In summary, there are several important findings from review of these studies on estimates of 
baseline perceived risk in self-identified, adult smokers and include: 2) Smokers actively seeking 
treatment for tobacco dependence or LDCT lung cancer screening report medium to high levels of 
perceived risk (Park et al., 2013; Sinicrope et al., 2010); 2) Smokers who are not actively seeking tobacco 
treatment or lung cancer screening report lower levels of perceived risk, if concerned about lung cancer 
(Carere et al., 2015; Park et al., 2013; Persky et al., 2013; Sinicrope et al., 2010); and 3) Individual 
characteristics of smokers were important contextual considerations when assessing their subjective 
opinion of smoking-related perceived risk. In order to account for the complexity of perceived risk in 
smokers and its effect on smoking-related outcomes, measurement should consider a variety of covariate 
smoking-related risk factors (McQueen, Swank, Bastian, & Vernon, 2008). Several of these contextual 
smoking risk factors are discussed below.  
 Risk Perception and Smoking Risk Factors. There are several contextual smoking risk factors 
that impact a smoker’s perceived risk for developing smoking-related health conditions and these include: 
age, race, smoking history, and the presence of a co-morbid health condition. There was a significant, 
inverse correlation between perceived risk and smokers between the ages of 50 and 75 years, indicating 
that older age is associated with lower levels of perceived risk (r= -0.13, p< .05) (Bunge et al., 2008). It 
was also reported that younger smokers perceive higher levels of health risk related to smoking compared 
to middle-aged and older smokers (Sinicrope et al., 2010). Mid-range levels of perceived risk were 
reported among older, high-risk smokers (e.g., those with a cumulative smoking history of 30 pack years 
or more), while lower levels of perceived risk were reported among older smokers with a pack-year 
history that was not high-risk (Sinicrope et al., 2010). Finally, smokers diagnosed with hypertension 
reported higher levels of perceived risk, when compared to smokers diagnosed with other chronic 
conditions (Borrelli et al., 2010). This finding suggests that smokers with cardiovascular disease (CVD; 
e.g., hypertension, stroke, etc.) may believe that quitting could contribute to improvement in overall 
health. 
Race and sex have also been found to influence health risk perceptions related to smoking. Race 
has been shown to influence perceptions of health risk based upon race-specific disease prevalence and 
cultural dissonance (Alberg & Samet, 2003; Haiman et al., 2006; Persky et al., 2013). For example, 
Blacks and Native Hawaiians perceive higher levels of risk for the negative health effects of smoking and 
this may in part because they are more susceptible than Whites, Asians (Japanese Americans), and 
Hispanics to complications of CVD, COPD, and lung cancer (Alberg & Samet, 2003; Haiman et al., 
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2006). Black people may be less likely to adopt behaviors to lower actual risk if care is received from a 
racially discordant medical provider, which can potentially impede a positive change in perceived risk, 
motivation to quit, and participation in lung cancer screening (Persky et al., 2013). Sex can also 
significantly affect perceptions of health related to smoking when women acknowledge stronger 
associations between perceived risk, motivation to quit, and tobacco treatment outcomes (McKee et al., 
2005; NIDA, 2012). There were no significant sex differences associated with perceived risk in the 
studies reviewed for this report.  
 
 
Synthesis of Theoretical Frameworks 
 
 
Perceived Risk and Outcome Expectancy 
 
Health risk perceptions related to smoking may be influenced by a number of psychological 
processes, including motivational factors, emotional responses, and numeracy barriers (Klein & Stefanek, 
2007). Understanding the relationships that exist between smoking beliefs, actions, and behavioral 
outcomes may explain how smokers regulate their behavior based upon personal expectations. Outcome 
expectations describe subjective beliefs that carrying out a specific behavior will lead to an expected, 
corresponding outcome and are highly correlated with perceived risk related to smoking (Tidey & 
Rohsenow, 2009). Negative smoking outcome expectancies that anticipate future health problems 
improve the likelihood that a smoker will continue to abstain from smoking after cessation (USDHHS, 
1989). Negative smoking outcome expectancies also lead to greater success with smoking cessation 
within the first week of a quit attempt (Wetter et al., 1994). Conversely, positive smoking outcome 
expectancies often precipitate a relapse after an attempt to stop smoking, and positive outcome 
expectancies of smoking’s effect on mood impedes successful smoking cessation (USDHHS, 1989; 
Wetter et al., 1994). This cognitive-behavioral link between expected outcomes of smoking actions and 
the concern for experiencing negative health consequences emphasizes the significance of evaluating the 
influence of a smoker’s interpretation of perceived health risks and other subjective beliefs.  
Smoking outcome expectancies reflect anticipated consequences of smoking behavior and include 
beliefs about positive and negative consequences (Johnson et al., 2008). Examples of smoking-related 
outcome expectancy statements are: “I enjoy the taste sensations while smoking” (positive); “Smoking 
helps me calm down when I feel nervous” (positive); and “The more I smoke, the more I risk my health” 
(negative). Smoking outcome expectancies are often self-fulling and, like perceived risk, are much more 
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likely to influence self-reported readiness to quit (RTQ), than actual smoking cessation (USDHHS, 1989). 
Studies identified positive associations between outcome expectancy and motivation to quit (Johnson et 
al., 2008; Tidey & Rohsenow, 2009). But, smoking outcome expectancies demonstrated predictive value 
with successful smoking cessation, which was enhanced when the smoker was exposed to evidence-based 
tobacco cessation interventions (Johnson et al., 2008; Tidey & Rohsenow, 2009).  
 
 
Risk Perception in Health Behavior Theories 
 
Health risk perception and similar cognitive constructs, such as outcomes expectancy, are 
featured among numerous prominent health behavior theories, including Social Cognitive Theory 
(Bandura, 1986), the Health Belief Model (Janz & Becker, 1984; Rosenstock, 1974), the Theory of 
Reasoned Action (Fishbein & Ajzen, 1975), the Precaution Adoption Process Model (Weinstein, 
Sandman, & Blalock, 2008), the Theory of Planned Behavior (Ajzen, 1985), and Self-Regulation Theory 
(Leventhal, Meyer, & Nerenz, 1980). Each theory posits that beliefs regarding the likelihood and 
magnitude of potential health outcomes shape behavior (Brewer et al., 2007). The Health Belief Model 
delineated separate constructs for perceptions of risk susceptibility and risk severity; however, risk 
severity has been less useful in explaining cancer prevention behaviors (Janz & Becker, 1984; Weinstein 
et at., 1989). Therefore, perceived risk in this study refers to an individual smoker’s perceptions of risk 
susceptibility, which is defined as the likelihood of developing a smoking-related health condition if they 
continue to smoke. 
 
 
The (modified) Model of Risk Information Seeking and Processing 
 
The original RISP model was proposed by Griffin, Dunwoody, and Neuwirth (1999) to explicate 
the complicated nature of risk, how individuals perceive risk, and the potentially serious consequences 
associated with some health hazards. The model proposes five key concepts (Table 1) that influence 
behavior, which include: information processing, information seeking and avoidance, informational 
subjective norms, perceived hazard characteristics (perceived risk), and individual characteristics. Before 
modification, the RISP model assumed that elevated risk perception could increase one’s desire for 
additional information, if the risk issue is unfamiliar (Griffin, Dunwoody, & Neuwirth, 1999). The RISP 
was subsequently enhanced by applying the entire model as an antecedent for preventive health behavior 
(Griffin, Dunwoody, & Yang, 2012).  
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A modified version of the Risk Information Seeking and Processing (RISP) model (Figure 1) best 
illustrates how behavioral intention to perform a specific act can influence behavior, when predicted by 
individual characteristics. Contrary to most health behavior theories, the RISP model is not limited in its 
focus to narrowly describe the direct interaction between health risk perception and behavior change. In 
the context of smoking and perceived risk, this theoretical model supports the position that smoking 
behaviors are influenced by the individual’s perceived health risk, as predicted by individual 
characteristics (e.g., attitude, subjective norms, and perceived behavioral control) (Griffin, Dunwoody, & 
Yang, 2012). 
 
 
Table 1. Key Concepts of the Risk Information Seeking and Processing Model  
 (Griffin, Dunwoody, & Yang, 2012) 
Theoretical Concept Definition Explanation 
Information processing The central factor of the RISP 
model. Gateway between 
communication-related variables and 
their potential impact on beliefs, 
attitude, and behaviors. 
Individuals adopt either putting 
forth effort into 
processing a message or not based 
upon: 
Capacity to process the information 
Motivation to go beyond heuristic 
processing to engage 
Information seeking and 
avoidance 
Greater need for information 
sufficiency is likely to motivate 
active information seeking, but 
information might be avoided if an 
individual perceives that they are 
sufficiently educated on a topic. 
  
Predictor for information use and 
processing. 
A different response might be 
observed for "routine" exposure to 
risk information, versus "non-
routine" risk exposure. 
An individual might devote more or 
less effort to avoid information that 
distresses or distracts them. 
Informational subjective norms Social environments influence an 
individual’s judgment about the 
amount of information that they feel 
they need to achieve their 
information processing goals. 
  
Personal beliefs about what others 
(especially relevant others) think 
they should know about a risk topic, 
or individuals' perceptions about 
what relevant others already know 
about the risk could indirectly drive 
seeking and processing. 
Perceived hazard characteristics Cognitive evaluations of the nature 
of a hazard could have a direct 
impact on an individual’s judgment 
of information sufficiency about the 
risk. 
Predictor for information use and 
processing. 
Elevated risk perception could 
increase one’s need for additional 
information if the risk issue is 
unknown or individuals might still 
desire additional information. 
Individual characteristics Demographic variables and other 
characteristics underlie risk 
information seeking and processing 
Predictor for information use and 
processing (e.g., education, past 
experience, relevant values, 
sociocultural). 
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Figure 1. Model of Risk Information Seeking and Processing (RISP) 
(Griffin, Dunwoody, & Neuwirth, 1999). 
 
 
The modified RISP Model (as an antecedent to preventive behavior) (Figure 2) has been applied 
in tobacco research to further illustrate associations between smoking behaviors (e.g., initiation, 
cessation) and the perception of smoking-related health risks and benefits (Noonan, Karvonen-Gutierrez, 
& Duffy, 2014; Song et al., 2009). This synthesized theoretical framework was constructed by isolating 
factors from the original RISP to combine with additional factors from the Heuristic-Systematic Model 
(HSM) of information processing and Theory of Planned Behavior (TPB) that are relevant to risk 
perception and communication (Ajzen, 1991; Eagly & Chaiken, 1993; Griffin, Dunwoody, & Yang, 
2012). The HSM framework is a widely recognized communication model that attempts to explain how 
people receive and process information to form judgements about risk (Eagly & Chaiken, 1993; Trumbo, 
1999). And, the TPB emphasizes the influence of individual characteristics on the process of health risk 
perception in relation to the development and maintenance of preventive health behaviors (Ajzen, 1991). 
And, the health risk perceptions operate through a similar ‘dual information’ process whereby a number 
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of individual factors influence a person’s beliefs about disease risk and their reaction to risk-related 
information. 
 
 
 
 
Figure 2. Modified RISP Model as an antecedent to preventive behavior. 
(Griffin, Dunwoody, & Yang, 2012). 
 
 
A tobacco intervention study that applies the modified RISP Model to examine perceived health 
risk could provide an opportunity to explore potential factors that cause variance in smoking behavior 
outcome variables (Finney et al., 2011; Griffin, Dunwoody, & Neuwirth, 1999). However, neither the 
original RISP model nor its enhanced, modified version was directly tested in any of the studies included 
in the literature review. Empirical evidence strongly supports the likely predictive influence of individual 
characteristics on the relationship between perceived risk for developing a smoking-related health 
condition and smoking-related outcomes, such as chronic disease severity, co-morbid conditions, 
sociodemographic variables, and cultural factors (Benkert et al., 2009; Borrelli et al., 2010; Jacobs et al., 
2006; Musa et al., 2009; Persky et al., 2013; Saha et al., 2010; Shofer et al., 2014; Sinicrope et al., 2010). 
 
 
Summary of Findings 
 
Despite the significant prevalence of smoking-related morbidity and mortality, smoker’s often 
underestimate the likelihood of experiencing negative health consequences as a result of continued 
cigarette smoking. A hospitalization presents a unique opportunity to implement tobacco treatment 
interventions and preventive screening activities among adult smokers. Smokers admitted for an inpatient 
hospital stay are captive audiences to receive professional advice about quitting, gain exposure to 
evidence-based treatment recommendations for tobacco dependence, and be assessed for eligibility to 
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undergo early detection lung cancer screening via LDCT. No investigation to date has been conducted to 
evaluate the relationship between perceived risk and smoking behaviors or lung cancer screening among 
hospitalized patients. The current study seeks to fill this research gap in tobacco literature and 
demonstrate the contextual influence of individual characteristics on health behavior outcomes.  
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Chapter III  
 
 
Methods 
 
 
Study Overview 
  
This study was conducted in partnership with the Tobacco Treatment Service (TTS) at Vanderbilt 
University Medical Center (VUMC) in order to gain access to adult, self-identified smokers admitted for 
an inpatient hospital stay. The purpose of this investigation was to evaluate a smoker’s change in 
perceived risk for developing a smoking-related health condition before (pre-TTS) and after (post-TTS) 
participant was exposed to an inpatient TTS and, to examine the influence of perceived risk, in the 
context of smoking risk factors, on subsequent smoking-related outcomes. In this chapter, details are 
provided related to the research design, sample, the inpatient TTS protocol, data collection procedures, 
survey instruments, and statistical analyses. Institutional Review Board (IRB) approval was obtained 
from Vanderbilt University. 
 
 
Research Design and Assumptions 
 
 
Research Design 
 
A non-experimental, single group, pretest-posttest, quantitative design was used to explore 
perceived risk in hospitalized smokers and investigate the influence of perceived risk on smoking-related 
outcomes, such as readiness to quit, smoking behavior variables, and lung cancer screening via LDCT. 
The predictor and outcome variables were determined at study enrollment and a three-month follow-up 
and evaluated using descriptive and correlational statistical analyses. After a single group of hospitalized 
smokers were exposed to a brief, inpatient tobacco treatment program, two measures of perceived risk 
were assessed along with smoking risk factors during study enrollment at the bedside. The single 
group design did not provide for a control group or any additional comparison groups. Therefore, no 
attempt was made to randomly assign smokers to study groups based upon level of perceived risk or 
any other smoking-related variable. Study outcome variables included readiness to quit which was 
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measured at study enrollment and smoking behaviors which were measured three-months later during 
follow-up via telephone or email communication. 
Perceived risk was assessed in the study to understand the degree in which the smoker 
acknowledged their likelihood of developing a smoking-related health condition. As previously 
addressed, two measurements of perceived risk were compared in order to explore how the smoker’s 
subjective beliefs regarding risk may have changed (increased, decreased, or stayed the same) after 
being exposed to a brief, inpatient tobacco treatment program. Due to the sample selection process, it 
was not feasible to assess the smoker’s perceived risk before exposure to the intervention. Therefore, 
both perceived risk measurements were measured at study enrollment, with the baseline (e.g., pre-
TTS) measurement of perceived risk assessed retrospectively. The first determination of perceived 
risk was measured immediately following informed consent and after TTS exposure; this 
determination was referred to as ’post-TTS perceived risk’. The second determination of perceived 
risk, referred to as “pre-TTS (retrospective) perceived risk” was measured next using an evaluation 
technique known as a retrospective pretest (Curtis & Drennan, 2013).  
 
 
Design Assumptions 
 
A single group, non-experimental design was used to explore how individual subjects respond to 
an experimental factor. This design approach is also likely to yield statistically relevant results despite 
limited time, resources, and number of participants (Byiersa, Reichlea, & Symonsa, 2012; Kazdin, 2010). 
A descriptive study design approach was utilized for Aim 1 to identify patterns and trends in perceived 
risk among hospitalized smokers, and a retrospective pretest of perceived risk was conducted to assess 
participant beliefs prior to inpatient TTS. A correlational research study design approach was utilized for 
the remaining aims to demonstrate if perceived risk among hospitalized smokers was related to or 
influenced the likelihood of the occurrence of various smoking-related outcomes. Due to limited 
empirical findings, smoking behaviors and related outcomes cannot be causally linked to perceived risk 
(Cook & Campbell, 1979; Kazdin, 2010; Shadish, Cook, & Campbell, 2002; Torgerson & Torgerson, 
2008). In addition, an attempt to interpret inferential relationships using data from this study may be 
subject to error because of confounding variables and validity threats such as history, maturation, test 
effects and regression to the mean (Cook & Campbell, 1979; Shadish, Cook, & Campbell, 2002).  
A retrospective pretest has been used in previously published behavioral intervention studies 
examining of perceived risk and other attitudes when it is not possible to use a traditional pre-post design 
and obtain a baseline measurement prior to the behavioral intervention (Kaushal, 2016; Klatt & Taylor-
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Powell, 2005a; Rhodes & Jason, 1987; Schwartz & Sprangers, 1999; Taminiau-Bloem et al., 2015). 
Utilizing a retrospective pretest method, participants rate their current levels of knowledge, skills, 
attitudes, or behaviors at the conclusion of the intervention, however they are asked to reflect back and 
rate their levels of knowledge, skills, attitudes, or behaviors prior to participating in the intervention. 
Limitations of a retrospective pretest design approach include issues concerning the capacity of a 
respondent to recall previous events and self-reported scores are subject to subject bias or social 
desirability (Pratt, McGuigan, & Katzev, 2000). However, strengths of a retrospective pretest method can 
attenuate a response-shift bias, provide a point of comparison during assessment, and more accurately 
measure change than simply perceptions of change (Ary, Jacobs, Razavieh, & Sorensen, 2006; Howard, 
1980; Pratt, McGuigan, & Katzev, 2000). Response-shift bias is a phenomenon that occurs when the 
respondent’s internal frame of reference significantly changes in during an intervention (a ‘program-
produced change’). As a result, the response given at baseline, prior to the intervention may be an 
inaccurate overestimation or underestimation (Howard, 1980; Pratt, McGuigan, & Katzev, 2000).  
 
 
Description of the Research Setting 
 
The study was conducted in partnership with the VUMC TTS. VUMC is an academic medical 
facility with over 100,000 inpatient admissions annually typically from Nashville-Davidson 
County/Murfreesboro/Franklin, Tennessee Metropolitan area, or rural regions outside of this metropolitan 
area in Tennessee or Kentucky. Approximately 18% of these inpatients report current use of cigarettes. 
The VUMC TTS is a comprehensive clinical inpatient service created to provide evidence-based tobacco 
treatment methodologies to adult, inpatient smokers at VUMC. These smokers were identified by self-
report during hospital admission after which their names are added to a TTS census within the electronic 
medical record (EMR). In 2016, the VUMC TTS census contained 5,667 smokers and 78.4% (n= 1,096) 
of these smokers had received the inpatient TTSs.  
The VUMC TTS provides brief, inpatient tobacco treatment to all self-identified, adult cigarette 
smokers, and offers evidence-based treatment methods, in accordance with recommended clinical 
guidelines (Rigotti et al., 2014). VUMC TTS services were provided by three tobacco treatment 
specialists during the study period (one nurse practitioner, one physician assistant and a cardiac 
rehabilitation registered nurse). During the final month of study recruitment, two additional tobacco 
treatment specialists were hired (a registered nurse and licensed health counselor). These two newly hired 
staff conducted a treatment counseling encounter to one study participant each.  
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The TTS care process/protocol (Appendix B) requires the tobacco treatment specialist to perform 
a preliminary chart audit of inpatient smokers followed by a bedside visit to provide advice about quitting 
and managing tobacco dependence and the use of different TTS modalities. The following inpatient TTSs 
services were provided and/or offered to inpatient smokers: 
1) An assessment of smoking status and lifetime smoking history (pack years); 
2) A motivational interview to identify factors that influence behavior change; 
3) Written educational materials;  
4) Recommendations for pharmacotherapy; 
5) A referral to the state tobacco quit line; and  
6) A referral for free lung cancer screening via (LDCT), if eligible.  
All elements of the TTS care protocol (Appendix B) were documented in VUMC’s EMR for 
every patient encounter. TTS documentation included specific smoking-related information required to 
evaluate smokers’ level of actual risk for adverse smoking outcomes and to determine eligibility for lung 
cancer screening via LDCT. TTS documentation also included patient responses to the 
recommendations/referrals for inpatient tobacco treatment services (pharmacotherapy or behavioral 
counseling) and/or lung cancer screening procedures via LDCT. The extent of inpatient tobacco treatment 
exposure for each smoker varied by how many of the six TTS services were delivered to the patient.  
TTS exposure was documented by the tobacco treatment specialist designating one of four 
treatment categories: 1) TTS consultation (comprehensive exposure with at least 4 out of 6 services 
delivered); 2) abbreviated TTS consultation (limited exposure with less than 4 services delivered); 3) 
TTS-declined consultation; or 4) TTS-not consulted. The TTS tobacco treatment specialist applied the not 
consulted category if the smoker was not appropriate for counseling due to altered mental status or 
diagnosis of a terminal disease (requiring hospice or palliative care). After the initial TTS consultation for 
tobacco treatment, the tobacco treatment specialist might offer follow-up communication during that 
same hospital stay or repeat counseling and treatment if the smoker required readmission into the hospital. 
Care coordination in this manner provided support for recommended pharmacological tobacco treatment 
and reinforced previously discussed behavioral cessation strategies. 
 
 
Sample and Sampling Plan 
 
 
Power Analysis 
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A power analysis was conducted with an effect size of 0.25, an alpha level of 0.05, and 80% 
statistical power. Regarding the effect size, no previous studies were suitable for use in calculating the 
appropriate effect size for testing the study hypotheses. Instead, the effect size and target sample size 
were set based on results of an analysis of the measure selected to assess health risk perception in this 
study (HINTS 4, 2014). The analysis confirmed that a sample size of 130 adult smokers admitted for an 
inpatient hospital stay at VUMC would achieve 80% statistical power to detect an effect size as small as 
0.25 (~6% shared variance) attributed to one independent variable (α= 0.05), assuming justification of 
linear relationships and without inclusion of any covariates (Cohen, 1988). Based upon this scenario, 
which accounted for a dropout rate of about 10%, as many as twelve (12) variables could be included in a 
linear regression analysis to produce stable coefficients and detect a small effect of the study’s main 
outcome, change in perceived risk. 
Sampling Plan. A recruitment plan was developed to enroll a minimum of 130 hospitalized 
smokers by actively recruiting two days per week and consenting at least five patients per week. Initial 
study procedures proposed recruitment to extend over a period of six months with the caveat that 
implementation of TTS clinical services and uptake of the TTS services may influence the ability to 
obtain the intended sample. This target sample size was deemed feasible to achieve during the proposed 
six-month study period given the fact that 5,667 smokers were admitted for inpatient care at VUMC 
between July 2014 and 2015, with 97.9% of those smokers between the ages of 18 and 77 years. 
However, each participating smoker was required to have been exposed to inpatient tobacco treatment via 
the VUMC TTS during that current hospital stay prior to recruitment and study enrollment. Participant 
enrollment was discussed with the research committee on a consistent basis after the study was initiated in 
order to reassess progress and sample estimates. Actual recruitment occurred more quickly than expected 
with as many as ten patients consented per week. The entire study period took place over six months from 
September 2016 to February 2017. Sample recruitment goals were met after approximately three months 
and follow-up was completed three months later.  
Study Sample. Although measures of perceived risk have been examined in relation to tobacco 
treatment and lung cancer screening, no published data were available to prospectively estimate potential 
sample characteristics. The literature review conducted for this study produced a heterogeneous collection 
of intervention studies based on demographic factors, and all were investigated in outpatient settings. Due 
to the limited data published concerning perceived risk in inpatient settings, it was not possible to 
approximate the prevalence of older, heavy (high-risk) smokers that would be eligible for lung cancer 
screening because the nursing staff at VUMC were not required to assess lifetime smoking history by 
pack years prior to July 2015. Reports of smoking prevalence in the U.S. suggest that older, adult smokers 
are generally heavy smokers and eligible for lung cancer screening via LDCT. This assumption was based 
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on the likelihood that older smokers initiated smoking cigarettes when they were 18 years old or younger 
and have smoked at least one-half to one pack of cigarettes per day for 30 years (CDC, 2017). In addition, 
a study that analyzed data from the National Lung Screening Trial (NLST) reported that 6.2% of the U.S. 
(over 40 years of age) population would be eligible for lung cancer screening via LDCT (Pinsky & Berg, 
2012). 
 
 
Criteria for Sample Selection 
 
Inclusion Criteria. Hospitalized smokers aged between 18 and 77 years who were seen by a 
tobacco treatment specialist for an initial consultation within the past two days (~48 hours) of the current 
inpatient stay were eligible for study enrollment. Study enrollment was confirmed after the smoker gave 
consent to continue participation until the follow-up time period of 3 months (~90 days). The VUMC 
TTS census of inpatient smokers in the EMR was accessed to identify smokers appropriate for screening. 
The age limits set for inclusion were based on Centers for Medicare and Medicaid (CMS) coverage 
guidelines for LDCT lung cancer screening and for two additional key reasons. Children (persons under 
the age of 18 years) who smoke are traditionally excluded from lung cancer risk prediction models (Spitz 
et al., 2007). Moreover, smokers older than 77 years are not typically eligible for LDCT imaging because 
advanced age may impede implementation of aggressive, life-saving cancer treatment interventions 
(American Lung Association, 2015).  
Exclusion Criteria.  Exclusion included the following:  1) TTS services were refused or 
incomplete according to documentation in the EMR; 2) existing documentation indicated a past history of 
lung cancer or an abnormal lung finding suspicious for malignancy (e.g., tumor, nodule, opacity, and 
other than COPD, asthma, or pneumonia); 3) patients were in isolation due to treatment of a 
communicable disease; 4) the patient was unable to comprehend, verbally respond, read, and write in 
English; and 4) barriers to follow-up communication were present (e.g., no personal access to a telephone 
or computer or the inability to communicate by either communication method).  
 
 
Participant Recruitment and Informed Consent 
 
 
Participant Recruitment 
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The VUMC TTS census of inpatient smokers was reviewed and if eligible, smokers were 
approached at the bedside to explain the purpose of the study and request informed consent. Consent was 
requested to authorize permission for the principle investigator (PI) to review documentation in the EMR 
related to smoking and to accept communication from the PI in thirty (1 month) and ninety days (3 
months). Consenting participants were asked if they preferred to be contacted by telephone, mobile text 
message, or electronic mail (email) at follow-up. In addition, participants were asked to confirm the 
phone number already documented in the EMR and provide a second phone number (e.g., personal, 
family member, friend). If applicable, the cellular carrier or email address was recorded into the database. 
Each of these features is further described as they are discussed in the context of data collection 
procedures. 
 
 
Informed Consent. The Vanderbilt University IRB and VUMC Office of Research granted 
approval to conduct research involving human subjects. Based on the inclusion criteria, the demographic 
and historical data concerning smoking behavior variables and comorbid health conditions of each 
eligible smoker were already recorded in the EMR in conjunction with services rendered by the VUMC 
TTS. However, separate IRB-approved recruitment procedures were necessary to allow the PI to collect 
pertinent information from EMR and administer the pre-post survey needed to assess change in perceived 
risk for developing a smoking-related health condition after exposure to a brief, inpatient tobacco 
treatment program. 
In accordance with the review criteria of the Agency for Health Care Research and Quality 
(2015), the consent document briefly highlighted the importance of participation in the study, knowledge 
to be gained, and potential benefits of discussing their personal attitudes and opinions of health risks 
related to smoking. All potential study participants were spoken to in the English language and given a 
written copy of the consent document, also in English, that explained the study design, intended 
objectives, plans for follow-up, and the right to withdraw from the study at any time. No monetary 
compensation was offered to incentivize study participation. If the smoker agreed to study enrollment, 
he or she was then asked for an electronic signature to acknowledge consent through the REDCap 
software database (Harris et al., 2008).  
 
 
Strategies to Ensure Human Subjects Protection. While investigating hospitalized, adult 
smokers, the disclosure of sensitive and/or personal health information (PHI) may be a source of risk for 
participants. Therefore, several steps were taken to protect the privacy, confidentiality, and retention of 
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human rights, welfare, and wellbeing of study participants (AHRQ, 2015). Risk of a privacy breach was 
minimized by adhering to the protocol already established by the TTS and only accessing participant 
information already disclosed via the standard of care at VUMC. Study data collected from EMR were 
stored on REDCap, a secured database safeguarded by Vanderbilt University’s technological 
infrastructure.  
The REDCap database software was utilized to create and distribute an electronic version of the 
questionnaires. Participant responses were entered into the REDCap database to ensure safe, secure 
storage and to allow export of data into a statistical package for analysis. Each live participant encounter 
was completed using a password protected handheld device. Data were collected using prepared scripts to 
increase the usability and replicability of the data. As the participant completed the survey, the PI was 
available for assistance. A key with participant identification numbers, medical record numbers, and 
patient names was kept in a secure Vanderbilt-sponsored cloud server. No identifiable information was 
retained about prospective participants who refused study participation. However, only de-identified data 
were downloaded from REDcap for analysis, and the anonymity of participants was protected using 
systematic aggregation. Finally, all identifiable data collected from the EMR (e.g., medical record 
numbers) will be destroyed after all analyses and publications related to the study have been completed 
and accepted. 
 
 
Procedures and Data Collection 
 
 
Study Procedures 
 
After approval from the Vanderbilt University IRB, all data collection procedures were 
completed by the PI. Prior to study initiation, the PI job shadowed the TTS tobacco treatment specialists 
to become familiar with the VUMC TTS care services and protocol processes. The PI was then able to 
compose the script used to recruit, consent, and survey participants to contain similar language used 
during the delivery of TTS inpatient tobacco treatment services. This element of data collection 
procedures was important to minimize the potential of creating unequal groups due to the presence of 
confounding variables introduced during data collection.  
After informed consent and confirmation of inclusion and exclusion criteria, data collection 
included the completion of survey instruments at the bedside, a chart audit of demographic and 
historical data concerning smoking risk factors and comorbid health conditions and acceptance of 
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tobacco treatment services (via VUMC TTS documentation), and completion of survey instruments at 
three-month follow-up (See Appendix C). There were three features of the recruitment and procedural 
methods unique to this study (Figure 3). First, post-TTS perceived risk was assessed within two days of 
exposure to an initial consultation for inpatient tobacco treatment. Second, perceived risk prior to 
inpatient tobacco treatment exposure was assessed retrospectively (by retrospective pretest) (Lamb, 
2005). Third, other independent and dependent study variables were assessed after study enrollment via 
chart audit of the EMR. 
Procedures at Study Enrollment. Study enrollment data were assessed using a brief survey (~ 5 
to 10 minutes) that contained questions about their 1) current level of perceived risk for developing a 
smoking-related health condition; 2) level of perceived risk prior to receiving tobacco treatment via 
retrospective pretest; and 3) current level of motivation, or readiness, to stop smoking cigarettes 
(Appendix C, Study Enrollment Survey Instrument). The survey was formatted in the REDCap database 
and administered electronically on a hand-held computerized device. The PI remained present to answer 
technology-related questions during administration. Among the 134 hospitalized smokers enrolled, all 
completed initial survey instruments. The baseline chart audit was completed within one week after 
study enrollment to assess details concerning participants’ smoking risk factors and acceptance of 
tobacco treatment services (via VUMC TTS documentation). Responses for this survey were also 
electronically recorded in the REDCap database. After participant recruitment concluded, an additional 
audit of the EMR was performed for each enrolled smoker to confirm the accuracy of the data.  
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Procedures at Study Enrollment. A convenience sample of 134 hospitalized, adult smokers  
 
  
Study Introduction and Informed Consent 
Would you allow me to ask you a few questions today concerning how you feel about your health as it 
relates to smoking? Would you also be willing to allow me to contact you twice after today - once in 30 
days and once more in 90 days- to follow-up and ask you similar questions about your health?  
Follow-up surveys can be completed online through email, text, or telephone call. 
All Baseline Data Collection Complete 
1-Month 
Follow-up Assessment  
Smoking behaviors 
n= 71 
Not LDCT-Eligible 
n= 92 
 
 LDCT-Eligible 
Older, High-Risk Smokers 
55-77 yo with ≥30 Pack Years 
n= 42 
Study Enrollment  
n= 134 (n= 14 refused) 
 
Accepted 
LDCT 
Referral 
n= 17 
 
Declined 
LDCT 
Referral  
n= 9 
3-Month 
Follow-up Assessment 
Perceived risk, Smoking behaviors, 
Readiness to quit, Completion of lung 
cancer screening via LDCT (N= 0) 
N= 63 
Study Enrollment Survey Measurement of Perceived Risk and Readiness to Quit 
 
Post-TTS Perceived Risk (after TTS exposure assessment) 
To evaluate perceived risk for developing a smoking-related disease after exposure to inpatient tobacco treatment 
 
Pre-TTS Perceived Risk (retrospective assessment of before TTS exposure) 
To evaluate perceived risk for developing a smoking-related disease before exposure to inpatient tobacco treatment 
 
Readiness to Quit (at study enrollment) 
To evaluate motivation, or readiness, to stop smoking cigarettes 
Chart Audit via VUMC EMR 
Data collection of demographic and historical smoking-related information 
 
 
No Offer 
of LDCT 
Referral  
n= 16 
 
148 prospective study participants were approached after exposure to inpatient tobacco treatment services 
rendered by the VUMC TTS 
Inclusion: Adult inpatient smokers 18 to 77 years old serviced by a VUMC TTS tobacco treatment specialist, 
Screened within 48 hours of initial TTS consultation, Willingness to participate 
Exclusion: Less than comprehensive TTS exposure, History of lung cancer or abnormal lung imaging suggestive 
of malignancy, English illiterate, No access to telephone or computer. 
Did not complete 
LDCT Screening 
 n= 11 
Complete LDCT 
Screening 
 n= 0 Figure 3. Subject Recruitment and Procedures. 
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Procedures at Follow-Up. Follow-up communication was completed with a messaging 
application in the REDCap database, one and three months after study enrollment. During each week of 
the study period, the PI searched the REDCap database to review communication timing and progress. 
Attrition was confirmed (at 1 and 3-month time periods) if the participant could not be reached after three 
separate, unsuccessful attempts (+/- 2 weeks of follow-up, separated by at least one day, and no more than 
seven days). Voicemail messages were not left for unanswered phone calls.  
One-month follow up survey instruments were conducted via telephone only using the phone 
number(s) confirmed during study enrollment. Although data collected at the one-month follow-up was 
not analyzed in the current study, communication at this point in time provided an opportunity to capture 
any historical data found missing in the EMR (e.g., education level, age of smoking initiation, subjective 
health literacy scores, etc.). If communication was unsuccessful, a second chart audit was conducted to 
locate missing data. At the three-month follow-up time period, survey instruments were delivered based 
upon the participants’ preferred method of communication (specified at study enrollment). Telephone 
calls were made manually, but surveys were also delivered to email and mobile text message addresses 
via a secure link through the REDCap database. After an attempt to electronically communicate over four 
weeks, participants were contacted by telephone.  
 
 
Data Collection Time Points 
 
Data collection ended for each participant after completion of the three-month survey and a final 
chart audit, if needed to verify self-report lung cancer screening activities. Otherwise, the smoker was 
designated a non-responder. Table 2 details all contact points and specifies when measurements of 
perceived risk, smoking risk factors, and smoking-related outcomes were examined at each data 
collection time point.  
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Table 2. Smoking Risk Factors and Behavior Outcomes Examined Across Data Collection Time Points  
Key Variable Measured 
Study 
enrollment 
1 month 3 months 
Perceived Risk    
Retrospective Individual (Lung Ca and SRD) x   
Retrospective Comparative (Lung Ca and SRD) x   
Individual (Lung Ca and SRD) x  x 
Comparative (Lung Ca and SRD) x  x 
Readiness to Quit    
Readiness to Quit Score x  x 
Smoking Behaviors    
Smoking Status** x x x 
Quit Attempt* x  x 
Subjective Number of Days Attempted*   x 
Number of Cigarettes Smoked per Day**  x  x 
Pharmacological Tobacco Treatment    
Recommendation Acceptance x   
Self-reported Use of NRT  x x 
Self-reported Use of Prescribed Pills  x x 
Type of Medication    x 
Behavioral Tobacco Treatment    
Referral Acceptance x   
≥ 1 Counseling Session; Self-reported  x x 
Lung Cancer Screening via LDCT    
Referral Acceptance x   
Completion of LDCT Scan***   x 
SRD= Smoking-related Disease; NRT= Nicotine Replacement Medication; LDCT= Low Dose Computed 
Tomography 
* Among current smokers    
** 30-day point prevalence    
*** Among participants 55-77 years old; 30 pack year smoking history 
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Survey Instruments for Independent Study Variables 
 
Perceived Risk for Developing a Smoking-Related Health Condition. Perceived risk was 
measured at study enrollment and three-month follow-up by modifying four items from the National 
Cancer Institute’s (NCI) Health Information National Trends Survey (HINTS). The HINTS survey 
systematically collects nationally representative data to gain insight into how people perceive cancer risks 
in order to create more effective health communication strategies across different populations (Nelson et 
al., 2004). Perceived risk is most accurately measured when survey items include four essential 
components: 1) who is at risk; 2) for what hazard; 3) over what period of time; and 4) a statement of 
current, personal behavior (Brewer et al., 2004). The risk perception question from the HINTS to assess 
personal perceived risk reads, “How likely do you think it is that you will develop ____ cancer in the 
future?,” and to assess comparative perceived risk, “Compared to the average {man/woman} your age, 
would you say that you are more likely to get ____ cancer, less likely, or about as likely?” (HINTS cycle 
1; HINTS 4, 2014; Nelson et al., 2004). 
Similar to other smoking behavior studies, the 4-item measure in this study was modified to 
assess personal and comparative perceived risk for developing lung cancer or other smoking-related 
cardiopulmonary diseases on a five-point ordinal response scale, with each step on the five-point scale 
corresponding to one unit (Hamilton et al., 2015; Nelson et al., 2004-2014, HINTS Cycle 1-4, 2014; 
Shofer et al., 2014). Perceived risk for developing lung cancer and smoking-related disease were 
measured as separate concepts because while LDCT may detect abnormal findings that indicate suspicion 
for lung cancer, imaging may also confirm the presence of heart disease or other lung conditions (Park et 
al., 2013). Therefore, survey items for the current study were altered to specify ‘lung cancer’ for two 
questions describing personal and comparative beliefs and ‘smoking-related disease’ for an additional two 
questions describing personal and comparative beliefs. Responses were then prepared for analysis by 
calculating a single interval/ratio level summary score for the set of four (4) personal and comparative 
perceived risk questions (Borrelli, Hayes, Dunsiger, & Fava, 2010; Bunge et al., 2008; Carere et al., 2015; 
Chena & Kaphingst, 2010; Harris et al., 2012; Shofer et al., 2014). Internal consistency for previous lung 
cancer data using Cronbach’s alpha reliability generally ranged from 0.88 to 0.93, exceeding the 
established acceptable criteria of 0.70 (Carter-Harris, Slaven, Monohan, & Rawl, 2016; Park et al., 2009). 
Contextual Smoking Risk Factors. A survey was used to assess demographic and historical 
data concerning smoking risk factors and comorbid health conditions. The TTS protocol directed the 
tobacco treatment specialist to solicit responses for many of the contextual smoking risk factors 
variables of interest. As a result, the majority of the data needed for analysis was found during a chart 
audit of TTS documentation in the EMR. Data to assess the remaining variables were also located in 
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the EMR, outside of TTS progress notes. An inclusive list of all smoking risk factor variables is 
provided below, and several variables are described in further detail: 
Sociodemographic Variables:  
o Participant Age, Sex, Race, Education Level, Subjective Health Literacy, 
Employment Status, and Household Income below Poverty Level 
Smoking Behavior Variables:  
o Smoking Status, Age of Smoking Initiation, Cigarettes Smoked per Day (CPD), 
Time to First Cigarette (TTFC), Lifetime Smoking History (Pack Years), 
Concurrent Other Tobacco Use, and Quit Attempt in the past 1 year  
Comorbid Smoking-Related Diseases:  
o Heart Attack (CVD), Stroke, Congestive Heart Failure (CHF), Diabetes, 
Hypertension, High Cholesterol, Chronic Kidney Disease/Chronic Kidney 
Insufficiency, Cancer, Chronic Obstructive Pulmonary Disease (CPOD), Pneumonia, 
and Asthma. 
Substance Abuse:  
o Illicit Drug Use, Risk for Alcohol Withdrawal 
Documented Psychiatric Diagnosis: 
o e.g., Depression, Anxiety, Bipolar Disorder, etc. 
Household Income. Household income below poverty level was analyzed as a dichotomous 
measure of poverty status according to the 2016 federal poverty level (FPL) guidelines from the U.S. 
Department of Health and Human Services (HHS). The poverty threshold per household size in 2016 was 
designated as follows: 1 = $11,880; 2 = $16,020; 3 = $20,160; 4 = $24,300; 5 = $28,440; 6 = $32,580; 7 = 
$36,730; and 8 = $40,890 (for households with more than 8 persons, add $4,160 to the FPL for each 
additional person). 
Subjective Health Literacy. Subjective health literacy was measured using the Brief Health 
Literacy Screen (BHLS), a concise and easily administered verbal screening tool useful in identifying 
hospitalized patients with low health literacy (McNaughton et al., 2009; Wallston et al., 2014). The 3-item 
measure is routinely administered at VUMC and documented in the EMR at admission. In previous 
studies, the Cronbach’s alpha for the BHLS was 0.80 and 0.74 among hospital patients, indicating high 
internal consistency reliability (McNaughton et al., 2009; Wallston et al., 2014. Tobacco literature 
indicates that after controlling for socio-economic factors, lower health literacy is associated with higher 
nicotine dependence, more positive smoking outcome expectancies, less knowledge about smoking health 
risks, and lower perceived risk (Stewart et al., 2013). 
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Lifetime Smoking History (Pack Years). A historical account of smoking habits and duration of 
smoking cigarettes was solicited in accordance with the TTS protocol. Pack years is a way to measure the 
amount a person has smoked over a long period of time (NCI, 2018). It is calculated by multiplying the 
number of packs of cigarettes smoked per day over time (lifetime smoking history) by the number of 
years the person has smoked (age of smoking initiation). For example, 1 pack year is equal to smoking 1 
pack per day for 1 year, or 2 packs per day for half a year, and so on. 
Nicotine Dependence. Nicotine dependence was assessed using a proxy measure the Fagerstrom 
Test for Nicotine Dependence (FTND), which is a standard instrument for assessing the intensity of 
physical addiction to nicotine (Heatherton et al., 1991). Nicotine dependence related to cigarette smoking 
is a significant risk factor for continued cigarette smoking and inhibits smoking cessation (Muscat, 
Stellman, Caraballo, & Richie, 2009; Gu, et al., 2014). The FTND contains six items that evaluate the 
quantity of cigarette consumption, the compulsion to use, and dependence (Heatherton et al., 1991). In the 
present study only 2 items from the FTND were used to determine nicotine dependence: self-reported 
time to the first cigarette (TTFC) and frequency (or amount) of cigarettes smoked per day (CPD). 
Other studies have also used one to two questions from the FTND and found the two-item 
measure (α= 0.70) (Pomerleau et al., 1994) or a single-item measure, self-reported time to first cigarette 
(TTFC) (α= 0.78) have good reliability. TTFC is negatively associated with objective lung cancer risk 
(p<0.001) and various measures for smoking status (e.g., cigarettes per day [r= 0.34], plasma cotinine [r= 
0.33], and urinary cotinine [r= 0.27]) (Gu et al., 2014; Muscat, Stellman, Caraballo, & Richie, 2009). The 
FTND score for this study also included TTFC, which was also converted from minutes to a four-point 
ordinal scale [1= 0-5 minutes; 2= 6-30 minutes; 3= 31-60 minutes, 4= >60 minutes]. 
Comorbid Smoking-Related Disease. The smoking-related diseases used to determine health 
status are widely associated with smoking-related outcome variables in tobacco research, such as smoking 
cessation and smoking-related mortality (Borrelli et al., 2010; Shofer et al., 2014). These specific diseases 
(with disease names listed) were included in the TTS protocol and retained for the current study. A count 
of smoking-related disease diagnoses was recorded and totaled from the TTS progress note and EMR. 
More rigorous methods to examine health status were not feasible. 
Substance Abuse. Evidence of current substance use related to alcohol, cannabis (marijuana), 
stimulants, hallucinogens, and opioids was determined by TTS and other EMR documentation. A positive 
response for substance abuse was also recorded if one of the following was found in the EMR: 1) active 
Clinical Institute Withdrawal Assessment for Alcohol (CIWA) protocol in place; 2) positive Audit-C 
alcohol screen; or 3) documentation of current substance use in a progress note during the present 
hospitalization. 
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Psychiatric Diagnosis. If a psychiatric diagnosis was not already documented in the smoker’s 
medical history, the TTS protocol mandated an evaluation for the presence of anxiousness or depressive 
symptoms using the 4-item, Patient Health Questionnaire-4 (PHQ-4) screening tool (Kroenke, Spitzer, 
Williams, & Lowe, 2009).  
 
 
Survey Instruments for Dependent Study Variables 
 
Change in Perceived Risk. To accomplish study aims of examining change in perceived risk, 
perceived risk was to be measured before exposure to inpatient tobacco treatment (pre-TTS) and after 
exposure to inpatient tobacco treatment (post-TTS). As noted above, pre-TTS assessment of perceived 
risk was assessed retrospectively, using a retrospective pretest (Curtis & Drennan, 2013). After responses 
were obtained for post-TTS perceived risk, the participant was asked to consider if interacting with the 
tobacco treatment specialist may have influenced their perception of smoking risks and previous 
responses. Then, pre-TTS (retrospective) perceived risk was determined by reading past tense questions 
to obtain a retrospective assessment: (e.g., ‘How likely did you think you were to get lung cancer in your 
lifetime?’). Summary scores were calculated for pre-TTS and post-TSS perceived risk. The ‘change’ in 
perceived risk can be statistically evaluated in different ways. In many smoking behavior studies 
examining change in risk perception, clinically significant changes have been designated as a one-unit 
change on a 5-point scale (Borrelli, Hayes, Dunsiger, & Fava, 2010; Bunge et al., 2008; Carere et al., 
2015; Chena & Kaphingst, 2010; Harris et al., 2012; Shofer et al., 2014). However, this method does not 
consider statistical comparisons of group means. By applying statistical analyses to compare group 
means, significant differences may be found when the actual change is relatively small but not clinically 
meaningful (Hawley, 1995). Also, this statistical comparison does not address the variability of individual 
outcomes within a sample.  
Reliable change indices (RCIs) provide a supplemental means of analysis to comparisons of 
group means in outcome research with preventive interventions, but this type of measurement is not 
known to have been used to evaluate changes in smoking-related outcomes (Jacobson, Follette, & 
Revenstorf, 1984; Jacobson & Truax, 1991). As a result, the magnitude and direction of an expected 
change in perceived risk cannot be estimated from the literature. RCIs have been more commonly used to 
appreciate behavior change in clinical psychology populations as therapy progressively moves the patient 
from dysfunction to function (Jacobson & Truax, 1991). Measurement of an RCI is used to evaluate 
statistically significant individual change in relation to the how the group demonstrated aggregate change 
(Hawley, 1995; Massen, Bossema, & Brand 2009). This method is accomplished by establishing a cutoff 
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point for clinically significant change and applying an index to measure the reliability of that change. 
Cases that exceed the clinical cutoff point are determined to be clinically significant. These findings result 
in a more meaningful interpretation of the data.  
Readiness to Quit (RTQ) Ladder. The RTQ Ladder (Figure 4) is a short, validated measure of 
readiness to consider smoking cessation that is generalizable for use with diverse populations to assess 
along a 10-point ordinal response scale (Abrams et al., 2003). Analyses of data collected from more than 
400 smokers were significantly associated with reported intention to quit, number of previous quit 
attempts, perceived co-worker encouragement to quit, and socioeconomic status (Herzog, Abrams, 
Emmons, & Linnan, 2000). Readiness scores also predicted subsequent participation in programs 
designed to educate smokers about related health risks (Herzog, Abrams, Emmons, & Linnan, 2000). The 
RTQ Ladder, which attempts to provide a socially acceptable way to indicate lower levels of readiness to 
consider quitting (Biener & Abrams 1991), was administered at study enrollment and at three-month 
follow-up. Most smokers are not motivated to quit. Readiness to quit is an important construct in smoking 
behavior studies to describe an individual’s desire, motivation, or intention to stop smoking cigarettes. 
According to the scale based on the Contemplation Ladder, a score of 10 corresponds to the statement “I 
have quit smoking and I will never smoke again;” and a score of 1 corresponds to the statement, “I enjoy 
smoking and have decided not to quit smoking for my lifetime”. RTQ was statistically evaluated both as 
an outcome variable influenced by perceived risk and other covariate factors and also as a smoking risk 
factor to predict smoking behaviors and lung cancer screening.  
 
 
 38 
 
 
Figure 4. Readiness to Quit Ladder (modeled after The Contemplation Ladder)  
(Biener and Abrams, 1991) 
 
 
Smoking Behavior Outcomes. Several smoking-related behaviors were assessed as outcome 
variables at three-month follow-up in order to identify volitional efforts to stop smoking cigarettes. These 
variables include smoking status; reduced consumption of cigarettes per day; participation in 
pharmacological tobacco treatment; participation in behavioral tobacco treatment; and lung cancer 
screening via LDCT among eligible older, high-risk smokers. A simplified survey was administered at the 
one-month follow-up to only assess smoking status and participation in inpatient tobacco treatment 
modalities.  
Smoking Status. Self-reported smoking status was assessed using a 30-day point prevalence for 
smoking cessation. Participants were asked to verify if they were smoking ‘every day’, ‘some days’, or 
‘not at all’. No attempt was made to biochemically verify smoking cessation because the inpatient tobacco 
treatment intervention was introduced as a standard of care, clinical service and not as a research protocol. 
Biochemical validation of smoking cessation was also not feasible due to constraints associated with cost 
and access to participants at follow-up.  
Quit Attempt at Three-Month Follow-Up. Self-report of a quit attempt was defined as whether or 
not the smoker abstained from smoking cigarettes for greater than one day because they were trying to 
quit, between study enrollment and at three-month follow-up. A “quit attempt” was assessed by asking 
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the participant if they had stopped smoking cigarettes for more than one day in an effort to quit smoking 
between study enrollment and three-month follow-up (since being hospitalized). A “quit attempt” was 
first measured dichotomously [1= Yes; 2= No]. If a positive response was given, the number of days quit 
was assessed on a continuous scale [1-90 days].   
Reduced Cigarette Consumption. The number of cigarettes smoked per day (CPD) was assessed 
at study enrollment using the value recorded into EMR tobacco treatment specialist, with a single number 
on a continuous scale [1-100 cigarettes]. At the three-month follow-up, self-reported CPD was reassessed 
based on the participants’ smoking status. CPD was not assessed if the patient had quit for greater than 30 
days. During data analysis, participant responses were evaluated to determine if they had significantly 
reduced the number of cigarettes smoked per day during the period of time between study enrollment and 
the three-month follow-up. A participant significantly ‘cut back’ or reduced cigarette consumption if their 
reduction in CPD was calculated to be greater than or equal to 50% (cigarettes per day/cutting back) 
relative to study enrollment CPD.  
Participation in Inpatient Tobacco Treatment. Participation in inpatient tobacco treatment 
modalities was confirmed by reviewing documentation of recommendation/referral acceptance of 
pharmacological and behavioral treatment options on TTS progress notes in the EMR. At follow-up, a 
self-report of use or participation was solicited. Participation in pharmacological tobacco treatment was 
defined as participant acceptance and the subsequent use of recommended FDA-approved nicotine 
replacement or prescription medications between study enrollment and follow-up time periods. 
Participation in behavioral tobacco treatment was defined as participant acceptance of the referral for 
state-sponsored quit line counseling and subsequent participation in at least one telephone counseling 
session. Referral acceptance and active use/involvement was analyzed at study enrollment as 
dichotomous data [1= Yes; 2= No]. Additional questions were queried if the participant gave a positive 
response at follow-up. A positive response indicating active use of pharmacotherapy prompted a question 
to explore the type of FDA-approved prescription medication used [choices were assigned numbers from 
0 to 7]. Similarly, a positive response indicating active participation with quit line counseling prompted a 
question to explore the number of quit line sessions the participant had completed [1-5+].  
Lung Cancer Screening via LDCT. Older, high-risk smokers were offered a referral to undergo 
early detection, lung cancer screening via LDCT. The TTS protocol provided instructions to calculate 
pack years and evaluate each smoker’s level of actual risk for developing adverse smoking outcomes. 
According to CMS guidelines for LDCT coverage eligibility, older, high-risk smokers were identified as a 
current or former smoker, aged 55 to 74 years with at least a 30-pack year history or quit less than 15 
years ago (CMS, 2014). If a referral for LDCT was offered, the tobacco treatment specialist documented 
the smoker’s response as ‘accept’ or ‘did not accept’ in the EMR. Completion of lung cancer screening 
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procedures was assessed at the three-month follow-up only because participants were not expected to 
have completed LDCT imaging prior to this time, given that an outside provider was responsible for 
scheduling the procedure. If a positive response was given to indicate the smoker had completed LDCT 
imaging, the participant was then asked to disclose any known imaging results. Self-reported completion 
of LDCT imaging required validation via a chart audit. 
 
 
Pilot Testing 
 
A pilot test was conducted during the first three weeks of participant recruitment to evaluate 
feasibility of participant screening procedures, recruitment processes, time required, and survey 
administration to measure perceived risk in smokers while in a hospital setting. Pilot testing concluded 
with no major modifications necessary for recruitment protocols, survey content, or interview methods. 
Therefore, preliminary data collected were retained and subjects recruited during the initial three weeks 
were included as part of the study sample. Data collected during pilot testing was not to be used to 
conduct any sample size estimations or hypotheses testing. However, piloting informed two additional 
procedural steps to mitigate recruitment and protocol adherence issues. The PI implemented a study-
specific 1) “eligibility-screening checklist” and 2) an “end of day” task list to follow in conjunction with 
the other established recruitment and enrollment procedures. Use of the eligibility-screening checklist 
significantly minimized the potential of consenting an ineligible smoker into the study. Also, initial data 
entry, updates to the screening registry, and scheduling for one and three-month follow-up assessments 
for newly recruited participants were verified by completing the “end of day” task lists. 
The pilot test also emphasized three areas of concern that threatened successful study 
implementation. First, hospitalized smokers are understudied in tobacco research and limited evidence 
impeded the ability predict a target sample size. To address this issue, special care was made to build 
rapport with smokers encountered during recruitment to improve the likelihood of enrollment and follow-
up. Second, participants may not understand the objective and instructions of the retrospective pretest 
assessment to evaluate perceived risk prior to inpatient tobacco treatment. In response, an attempt was 
made to minimize the potential occurrence of a response error by communicating all instructions clearly 
and according to the script during the administration of each survey. Third, the success of examining the 
influence of perceived risk on smoking-related outcomes was heavily dependent on how thoroughly the 
TTS tobacco treatment specialist assessed and recorded participant historical data about smoking risk 
factors prior to study enrollment. This final issue was ameliorated by routinely attending TTS staff 
meetings to understand barriers encountered and learn of changes made to the TTS care process.   
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Statistical Analysis 
 
Two fundamental goals guided procedures for the data analysis plan. The first goal was to 
determine if inpatient tobacco treatment (e.g., the brief bedside session delivered by the VUMC TTS) 
influenced a change in perceived risk for developing a smoking-related health condition among 
hospitalized smokers. The second goal was to determine whether perceived risk in the context of smoking 
risk factors influences the following smoking outcomes: readiness to quit, smoking status, participation in 
inpatient tobacco treatment modalities, and participation in lung cancer screening via LDCT. Smoking 
risk factors previously identified in tobacco literature to significantly influence smoking-related outcomes 
were evaluated for each aim. The predictor variables measured at study enrollment included pre-TTS 
(retrospective) perceived risk, post-TTS perceived risk, RTQ, TTFC, CPD, participant age, concurrent 
other tobacco use, comorbid smoking-related disease, subjective health literacy, household income below 
poverty level, and education level.  
Data analyses were conducted using the Statistical Package for the Social Sciences (SPSS, 2017). 
After all three-month follow-up assessments were complete, preliminary analyses of descriptive statistics 
for all study variables were computed for evaluation of data accuracy, outliers, data transformation, issues 
related to collinearity, and missing data. As this was an observational study, no interim analyses were 
planned. Data entry accuracy was confirmed by directly importing de-identified data entries from 
REDCap to an SPSS data set. Tukey’s boxplots were used to determine potential outliers and 
multicollinearity was assessed among predictor variables by examining tolerance and the Variance 
Inflation Factor (VIF). No outliers were identified, and none of the variables were found to be collinear. 
No variables were removed from preliminary analyses.  
Before applying bivariate and multivariate statistical procedures, perceived risk and subjective 
health literacy scale scores were calculated, along with a Cronbach’s alphas for comparison to similar 
studies. Also, participation in inpatient tobacco treatment was determined by calculating the number of 
participants who engaged (used medications or participated in at least one counseling session) between 
study enrollment and three-month follow-up divided by the number of participants who accepted a 
referral at study enrollment. Other variable responses were recoded to facilitate ease of analysis. In all 
cases, ‘do not care to respond’ and ‘do not know’ responses to survey items were recoded as missing. 
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Data Reduction Techniques 
 
Sociodemographic Variables. Race, education, employment status, and household income 
below poverty level were recoded from categorical or ordinal variables to dichotomous variables. 
Although ethnicity and race were assessed separately at study enrollment, ethnicity was not included in 
the final analysis due to the relatively low percentage of Hispanic participants. Participant responses for 
race were combined into two categories: ‘White’ or ‘non-White.’ Education was recoded to reflect 
whether the participant had been educated at/above or below the high school level. Employment status 
was dichotomized into ‘working’ or ‘not working’. Finally, annual household income was recoded to 
identify if the participant earned an annual household income ‘above’ or ‘below’ the 2016 federal poverty 
line. 
Smoking Risk Factors and Outcomes. TTFC, smoking status, and reduction in cigarette 
consumption were recoded for data analysis. Data for TTFC were re-coded in order to classify data into 
categories with an equal number of units in each ordinal category. Smoking status (‘every day’ vs. ‘some 
days’ vs. ‘not smoking at all’) at the three-month follow-up assessment was recoded to reflect a 
dichotomous variable: ‘current smoker’ vs. ‘non-smoker’. The ‘current smoker’ variable was designated 
to include both ‘every day’ and ‘some days’ smokers. Also, significant reduction in CPD was recoded to 
be analyzed as a dichotomous variable: significant CPD reduction (≥ 50%) vs. no significant CPD 
reduction (< 50%). Percent reduction in CPD was calculated by subtracting CPD at three-month from 
CPD at study enrollment then dividing the difference by CPD at study enrollment.  
 
 
Management of Missing Data 
 
Missing and incomplete data were carefully examined with the assistance of SPSS to detect any 
significant patterns that would prevent the study from achieving 80% power. Data were missing at 
random due to attrition and participants declining to respond to certain survey items (e.g., household 
income, education). Patterns of missing data were also random and similar between groups. An intent-to-
treat (ITT) analysis was used to examine missing data to include data from all smokers who completed 
the study enrollment survey (n=134). This approach was chosen because estimates of the treatment effect 
in an ITT analysis is generally conservative and avoids potential complications during analyses that could 
result from missing data (Shadish, Cook, & Campbell, 2002).  
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Preliminary Analyses  
 
Descriptive statistics were used to summarize sociodemographic characteristics, perceived risk, 
smoking-related outcomes, potential covariates (e.g., TTFC, CPD). Parametric data findings were 
reported whenever appropriate. A summary of the statistical methods applied to achieve study aims will 
follow. All hypotheses were tested using a significance level of less than or equal to 0.05. Bivariate 
correlation analyses were further evaluated using Bonferroni’s correction (α= 0.05/10 = 0.005).  
Means and standard deviations were analyzed for continuous variables, and proportions were 
analyzed for categorical variables. Independent t-tests, Chi-square tests of independence, or Mann-
Whitney U tests, as appropriate, were also performed to assess for significant differences between 
participants who responded during the three-month follow-up and non-responders who did not respond. 
Pearson product-moment (r), Spearman’s rho (ρ), and Point-Biserial (rpb) correlational analyses were 
computed to examine correlations between perceived risk and smoking risk factors in hospitalized 
smokers measured at study enrollment. Pearson’s correlation tests were used for pre-TTS (retrospective) 
perceived risk, participant age, age of smoking initiation, (CPD), subjective health literacy, comorbid 
smoking-related disease, and lifetime smoking history (pack years); Spearman’s rank tests were used for 
post-TTS perceived risk, TTFC, and education level; and Point biserial correlation tests were used for sex, 
race, employment status, and household income based upon poverty level, smoking status, concurrent 
other tobacco use, and quit attempt in the past 1 year, illicit drug use, risk for alcohol withdrawal, and 
psychiatric diagnosis. Cronbach’s alpha analyses demonstrated high internal consistency reliability for 
both perceived risk and subjective health literacy measures used in the study (pre/post-TTS perceived 
risk: α= 0.92 and subjective health literacy: α= 0.89). Change in perceived risk was evaluated using 
reliable change indices (RCIs). Finally, regression analyses were conducted to estimate the relationships 
between perceived risk, in the context of smoking risk factors, and smoking-related study outcomes.  
 
 
Analyses by Study Aim 
 
Statistical Analyses for Aim 1. The first aim was to describe the nature and extent of change in 
perceived risk for developing a smoking-related health condition among hospitalized smokers after 
exposure to a brief, inpatient tobacco treatment program. Summary scale scores were computed for pre-
TTS and post-TTS perceived risk for internal consistency using a Cronbach’s alpha measure of reliability. 
To accomplish Aim 1, the extent and nature of change in perceived risk between pre-TTS and post-TTS 
was examined by calculating reliable change indices for this single group of hospitalized smokers. The 
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calculated RCI was used to determine a cutoff score to compare change in each individual pair of pre-
TTS/post-TTS perceived risk scores. The cutoff was computed by dividing the difference between the 
pre-TTS and post-TTS scores by the standard error of the difference between the two scores and defined 
in terms of the reliability of the measurement instrument (Maassen, Bossema, & Brand 2009).  
Reliable change can be evaluated, in mutually exclusive populations, when the client 1) moves 
beyond dysfunction, if the second measurement falls at least two standard deviations above the 
dysfunctional mean or 2) moves into normal, if the second measurement falls at least two standard 
deviations above the normal mean (Jacobson, Follette, & Revenstorf, 1984; Jacobson & Truax, 1991).   
The RCI analysis in this study provides results that include the statistically significant level of reliable 
change score and an effect size. If participant change scores exceed the RCI cutoff score, then perceived 
risk can be said to be significantly changed, meaning that the observed change would be expected by 
chance alone at a probability of less than 5%. Participant change scores within the band of no reliable 
change are said to not be significantly change. The effect size was calculated to indicate the strength of 
the observed change in perceived risk, as it represents the difference between two means assuming that 
two groups have similar standard deviations and are of similar size (Cohen, 1988). 
Statistical Analysis for Aim 2. The second aim was to identify relationship patterns between 
readiness to quit and pre-TTS (retrospective) perceived risk, in the context of smoking risk factors, at 
study enrollment. The RTQ score is a psychological measure that produces a continuous data value from 
1 to 10. The ladder attempts to provide a socially acceptable way to indicate lower levels of readiness to 
consider quitting (Biener & Abrams 1991). A multiple linear regression analyses was ideal to examine 
relationships with the continuous data values corresponding to RTQ Ladder scores at study enrollment. A 
regression analysis could also identify how much each predictor variable uniquely contributed to the 
relationship with readiness to quit. However, the regression model was over fit to accommodate the 
number of estimates included in the original analysis due to an insufficient sample size at three-month 
follow-up. Therefore, simple linear regressions were examined to identify the presence of statistically 
significant relationships between individual smoking risk factor variables and readiness to quit. In 
addition, a multivariate regression analysis was conducted to estimate relationships only between 
readiness to quit perceived risk, and two other smoking risk factors using a significance threshold of p< 
0.1.  
Statistical Analysis for Aim 3. The third aim was to identify the statistical influence of pre-TTS 
(retrospective) perceived risk, in the context of smoking risk factors, on smoking behavior outcome 
variables (smoking status, 3-month quit attempt, reduced cigarette consumption, and participation in 
inpatient tobacco treatment) at the three-month follow-up. Smoking cessation prevalence rates were 
determined by evaluating the number of participants reporting 30-day point prevalent smoking abstinence 
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in relation to the number of participants who reported they continued to smoke (‘every day’ or ‘some 
days’) at three-month follow-up. Prevalence rates of making a quit attempt rates were determined by 
evaluating the number of participants self-reporting abstaining from smoking for more than one day in an 
effort to stop smoking in relation to the number of participants who did not self-reported abstaining 
between study enrollment and follow-up at three months. Finally, prevalence rates of significant reduction 
in cigarette consumption at three-month follow-up were determined by evaluating the number of 
participants who self-reported 30-day point prevalent smoking abstinence and smoked at least 50% less 
CPD compared to CPD at study enrollment in relation to the number of participants who did not quit or 
reduced their CPD by at least 50%. Participation rates of inpatient tobacco treatment modalities were 
evaluated to measure efficiency of the inpatient tobacco treatment program.  
The aim was accomplished by conducting univariate logistic regression analyses. All smoking 
behavior outcome variables were analyzed as dichotomous variables. However, perceived risk and other 
predictor variables could not be entered into the equation simultaneously due to an insufficient sample 
size at the three-month follow-up. Relationships between participation in behavioral tobacco treatment via 
the state tobacco quit line and independent variables could not be evaluated due to poor rates of 
participation.   
Statistical Analysis for Aim 4. The fourth aim was to identify relationship patterns between 
completion of lung cancer screening via LDCT and pre-TTS (retrospective) perceived risk, in the context 
of smoking risk factors, at three-month follow-up. There was no data available to examine potential 
relationships due to a complete lack of participant reporting for LDCT completion at three-month follow-
up. 
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Chapter IV 
 
 
Results 
 
 
Introduction 
 
This chapter describes the enrollment and characteristics of the sample population, identifies 
associations among study variables, and reports results for the four study aims to: (1) identify the extent 
and nature of change (from before inpatient tobacco treatment [pre-TTS] to after inpatient tobacco 
treatment [post-TTS]) in perceived risk of smoking-related health condition among hospitalized smokers 
exposed to a brief, inpatient tobacco treatment program; (2) evaluate the influence of perceived risk of 
smoking-related health condition, in the context of smoking risk factors, on readiness to quit smoking 
among hospitalized smokers exposed to a brief, inpatient tobacco treatment program; (3) determine 
relationships between perceived risk of smoking-related health condition, in the context of smoking risk 
factors, and subsequent smoking-related outcomes among hospitalized smokers exposed to a brief, 
inpatient tobacco treatment program; and (4) determine the relationship between perceived risk of 
smoking-related health condition, in the context of smoking risk factors, and completion of lung cancer 
screening imaging via LDCT among older, high-risk, hospitalized smokers exposed to a brief, inpatient 
tobacco treatment. 
 
 
Characteristics of Hospitalized Smokers at Enrollment and Three-Month Follow-up 
 
The enrollment period of hospitalized smokers exposed to inpatient tobacco treatment occurred 
between September 2016 and February 2017. During this time, a total of 1,398 self-identified, inpatient 
smokers were identified via the electronic hospital record. The majority (n= 1,096; 78.4%) of them were 
approached by certified tobacco treatment specialists (CTTS) from the Vanderbilt University Medical 
Center (VUMC) Tobacco Treatment Service (TTS) and were offered tobacco treatment counseling. Three 
hundred and two (302) hospitalized smokers either declined counseling or did not meet TTS inclusion 
criteria for consultation. For the current study, only those subjects (n= 409) who were counseled for the 
first time during the initial invitation were considered for participation in this study; and among this 
group, 148 met preliminary study eligibility criteria (Figure 5).  
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TTS Hospitalized Smokers 
Screened for Eligibility (n= 409) 
675 smokers on VUMC TTS census 
175 duplicate names 
 
 
Study Enrollment 
1-month Follow-up Completed  
(n= 72; 53.7%) 
Ineligible for Inclusion: (n= 261; 63.8%) 
* Declined TTS consultation  (n= 66) 
* Abbreviated TTS consultation (n= 40) 
* Progress TTS consultation  (n= 54) 
* Lung Ca/Nodule Surveillance  (n= 34) 
* Isolation Precautions   (n= 17) 
* Discharged prior to approach  (n= 21) 
* Unavailable prior to consent  (n= 24) 
* Communication barrier  (n= 5) 
 
1-Month Follow-Up Time Period 
TTS Hospitalized Smokers  
Consented for Participation  
(n= 134; 90.5%) 
 
 
Failure to follow-up at 1-month (n= 62; 46.3%) 
* Failed communication (n= 59) 
* Refused follow-up (n= 2) 
* Death Reported  (n= 1) 
 
Failure to follow-up at 3-month (n= 71; 53.0%) 
* Failed communication (n= 64) 
* Refused follow-up (n= 3) 
* Death Reported  (n= 4) 
 
Declined Participation 
(n= 14; 9.5%) 
TTS Hospitalized Smokers  
Approached for Recruitment  
(n= 148; 36.2%) 
3-months Follow-up Completed  
(N= 63; 47.0%) 
Figure 5. CONSORT Flow Diagram 
 
3-Month Follow-Up Time Period 
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Of all hospitalized smokers who were eligible for study inclusion, 14 (9.46%) declined to 
participate in the study. Therefore, a total of 134 subjects (90.54% of eligible patients) were enrolled in 
the current study. The average ages of those that refused and those that participated in the study were 
similar (49.14 years vs. 50.03 years, respectively), but more females (64%) refused participation 
compared to males (36%). Only 63 (47.0%) subjects, herein designated ‘participants’ completed the study 
(from enrollment to through the 3-month follow-up), with a 53.0% attrition rate (n= 71 non-responders). 
Ninety percent (90.0%) of non-responders could not be reached via telephone, electronic mail, or mobile 
text communication and a small percentage refused assessment (4.2%) or were deceased (5.6%). Non-
responders were somewhat younger, experienced more unemployment, and were below the household 
income poverty level compared to the participant group (Table 3). Other demographic characteristics 
were not significantly different between groups. However, more non-responders accepted 
pharmacological recommendations compared to the participant group (Table 3). Though more non-
responders than participants were positive for illicit drug use, there were no other differences in smoking 
characteristics and behaviors or comorbid smoking-related disease between participants and non-
responders (Table 3). 
Table 4 provides an overview of the medical diagnoses of all ‘total’ subjects initially enrolled in 
the study.  The three most frequently reported smoking-related medical diagnoses of enrolled individuals 
were hypertension (59.7%), hyperlipidemia (44.0%), and COPD (41.0%); and the least commonly 
reported diagnoses were chronic kidney disease (11.2%), asthma (10.4%), and a previous CVA (9.7%).  
The most prevalent primary hospital admitting diagnoses were circulatory (31.3%), digestive (12.7%), 
respiratory (9.7%), and musculoskeletal (9.7%) disorders; no subjects were admitted, however, with a 
primary diagnosis of cancer, alcohol use or mental disorders, or disorders of the blood. Upon release from 
the hospital, the majority (69.3%) of subjects were discharged to return to their home in the community 
(Table 4). Comparing participants and non-responders, a medical diagnosis of congestive heart failure and 
discharge disposition significantly influenced the likelihood of study participation at three-month follow-
up. 
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Table 3. Characteristics of Hospitalized Smokers Exposed to Inpatient Tobacco Treatment 
 
Subject Demographic and Smoking Characteristics 
 
Total sample 
(n= 134) 
 
Participants 
(N= 63) 
 
Non-responders 
(n= 71) 
 
p-value 
  
 M ± SD 
Median (IQR) 
n (%) 
M ± SD 
Median (IQR) 
n (%) 
M ± SD  
Median (IQR) 
n (%) 
 
Sociodemographic Variables 
    Participant Age 50.03 ± 13.95 53.57 ± 12.95 46.89 ± 14.14 .005a* 
    Sex: Male 71 (53.0%) 31 (49.2%) 40 (56.3%) .409c 
    Race: White 104 (77.6%) 51 (81.0%) 53 (74.6%) .623c 
    Education: High School Graduate/GED or better (n= 112) 78 (69.6%) 40 (66.7%) 39 (73.1%) .248c 
    Subjective Health Literacy Score (n= 131) 13.0 [10 – 15] 14.0 [11 – 15] 12.5 [9 – 15] .163b 
    Unemployed (n= 131) 88 (67.2%) 38 (61.3%) 50 (72.4%) .002c* 
    Below the Household Income Poverty Level (n= 115) 61 (53.0%) 22 (42.3%) 39 (61.9%) .036c* 
Smoking Characteristics and Behaviors 
    Perceived Risk Scale Score (pre-TTS, retrospective) 3.43 ± 1.05 3.36 ± 1.04 3.49 ± 1.06 .468a 
    Perceived Risk Scale Score (post-TTS) 4.00 [3.25 – 4.00] 4.00 [3.25 – 4.75] 4.00 [3.06 – 4.50] .740b 
    Readiness to Quit Score 6.98 ± 2.20 7.13 ± 2.14 6.85 ± 2.27 .460a 
    Every Day Smoker  127 (94.8%) 59 (93.7%) 68 (95.8%) .581c 
    Age of Smoking Initiation (n=133) 16.72 [13 – 18] 15.00 [13 – 18] 16.00 [13 – 18] .849b 
    Cigarettes smoked per day 20.00 [10 – 20] 15.00 [8.5 – 20] 20.00 [10 – 20] .069b 
    Time to First Cigarette (n= 132)    .957c 
               3= Within 5 minutes 67 (50.8%) 31 (50.0%) 36 (51.4%)  
               2= 6-30 minutes 33 (25.0%) 15 (24.2%) 18 (25.7%)  
               1= 31-59 minutes 9 (6.8%) 5 (8.1%) 4 (5.7%)  
               0= 60 minutes or more 23 (17.2%) 11 (17.7%) 12 (17.1%)  
    Pack Year History (n= 132) 30.00 [16.25 – 49] 34.40 [19 – 50.75] 28.00 [10.88 – 
46.13] 
.135b 
    Concurrent Other Tobacco Use (n= 132) 19 (14.4%) 11 (17.7%) 8 (11.4%) .302c 
    Quit Attempt in the past 1 year (n= 133) 9 (6.8%) 4 (6.3%) 5 (7.1%) .856c 
Tobacco Treatment Services 
    Accepted Pharmacological Recommendations (n= 133) 94 (70.7%) 38 (60.3%) 56 (80.0%) .013c* 
    Accepted Quit Line Referral (n= 127) 68 (53.5%) 26 (44.8%) 42 (60.9%) .071c 
    Accepted Lung Cancer Screening Referral (n= 42 eligible) 17 (40.5%) 11 (47.8%) 6 (31.6%) .481c 
          Eligible for LDCT, Refused Referral 9 (21.4%) 5 (21.7%) 4 (21.1%)  
          Eligible for LDCT, Not Offered Service 16 (38.1%) 7 (30.4%) 9 (47.4%)  
Substance Abuse/Psychiatric Conditions 
    Documented Illicit Drug Use 27 (20.1%) 9 (14.3%) 18 (25.4%) .111c 
    Documented Audit-C/Risk for Alcohol Withdrawal (n= 133) 33 (24.6%) 14 (22.2%) 19 (27.1%) .512c 
    Documented Psychiatric Diagnosis (n= 133) 61 (45.5%) 33 (52.4%) 28 (40.0%) .152c 
a Independent Samples T-test  b Mann-Whitney  cChi-Square Test of Independence  
Audit-C= The Alcohol Use Disorders Identification Test (modified) PHQ-4= The Patient Health Questionnaire-4 TTFC= Time 
to First Cigarette Subjective Health Literacy (3 to 15) Readiness to Quit scores (1 to 10) Lung Cancer Screening via LDCT: 
current or former smoker within 15 years; 55-77 years old; ≥30 pack year smoking history  
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Table 4. Prevalence of Medical Diseases and Discharge Characteristics among Hospitalized Smokers 
Exposed to Inpatient Tobacco Treatment 
Significant test: Chi-Square Test of Independence  aMann-Whitney 
Medical Diagnoses and Discharge information source: Vanderbilt University Medical Center’s EMR  
 
Smoker Medical Characteristics 
 
 
Total sample 
(n= 134) 
 
Participants 
(N= 63) 
 
Non-responders 
(n= 71) 
p-value 
 
     
 M ± SD 
Median (IQR) 
n (%) 
M (SD) 
Median (IQR) 
n (%) 
M (SD) 
Median (IQR) 
n (%) 
 
Smoking-Related Medical History at Study Enrollment 
     Hypertension 80 (59.7%) 39 (48.8%) 41 (51.3%) .624 
     Hyperlipidemia 59 (44.0%) 32 (54.2%) 27 (45.8%) .137 
     COPD (Chronic Bronchitis/ Emphysema) 55 (41.0%) 27 (49.1%) 28 (50.9%) .688 
     Heart Disease (Heart Attack/CABG/PCI) 41 (30.6%) 21 (51.2%) 20 (48.8%) .517 
     Diabetes 35 (26.1%) 20 (57.1%) 15 (42.9%) .163 
     Pneumonia 30 (22.4%) 16 (53.3%) 14 (46.7%) .431 
     None Reported 27 (20.9%) 12 (42.9%) 16 (57.1%) .620 
     Congestive Heart Failure 24 (17.9%) 16 (66.7%) 8 (33.3%) .033* 
     Cancer, Not Lung 23 (17.2%) 11 (47.83%) 12 (52.17%) .932 
     Chronic Kidney Disease 15 (11.2%) 9 (60.0%) 6 (40.0%) .285 
     Asthma 14 (10.4%) 7 (50.0%) 7 (50.0%) .813 
     Stroke 13 (9.7%) 4 (30.8%) 9 (69.2%) .219 
     Number of comorbid smoking-related diseases 2 [1 – 4] 3 [1 – 4] 2 [1 – 4] .211a 
Hospitalization Primary Discharge Diagnoses at Study Enrollment 
     Diseases and Disorders of the Circulatory System 46 (34.3%) 22 (47.8%) 24 (52.2%) .976 
     Diseases and Disorders of the Digestive System 17 (12.7%) 8 (47.1%) 9 (52.9%) - 
     Diseases and Disorders of the Respiratory System 10 (7.5%) 6 (60.0%) 4 (40.0%) - 
     Diseases and Disorders of the MSK System 11 (8.2%) 5 (45.5%) 6 (54.5%) - 
     Diseases and Disorders of the Nervous System 5 (3.7%) 3 (60.0%) 2 (40.0%) - 
     Endocrine/Nutritional/Metabolic Diseases  6 (4.5%) 3 (50.0%) 3 (50.0%) - 
     Diseases of the Kidney and Urinary Tract 4 (3.0%) 1 (25.0%) 3 (75.0%) - 
     Mental Diseases and Disorders 1 (0.7%) 0 (0%) 1 (100%) - 
     Diseases of the Hepatobiliary System and Pancreas 5 (3.7%) 1 (20.0%) 4 (80.0%) - 
     Alcohol/Drug Use or Induced Mental Disorders 3 (2.2%) 2 (66.7%) 1 (33.3%) - 
     Infectious/Parasitic/Systemic Diseases 9 (6.7%) 4 (44.4%) 5 (55.6%) - 
     Diseases of the Skin/Subcutaneous Tissue/Breast 3 (2.2%) 1 (33.3%) 2 (66.7%) - 
     Lymphatic/Heme/Onc Diseases and Disorders 2 (1.5%) 1 (50.0%) 1 (50.0%) - 
     Poisonings, Toxic Effects, Injuries/Complications 12 (9.0%) 6 (50.0%) 6 (50.0%) - 
Discharge Disposition n= 62 at 3-mo follow-up 
     Home with Self or Caregiver Care 92 (68.7%) 42 (45.7%) 50 (54.3%) .045* 
     Home with Home Health 24 (17.9%) 16 (66.7%) 8 (33.3%) - 
     Skilled Nursing Facility 15 (11.2%) 4 (26.7%) 11 (73.3%) - 
     Long-Term Care Facility 2 (1.5%) 0 (0%) 2 (100%) - 
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 Smoking characteristics and behaviors at enrollment and the three-month follow-up are shown in 
Table 5. The readiness to quit (RTQ) score was the only statistically significant change identified at the 
three-month follow-up, which decreased from 6.98 to 6.43 (p=0.03). Though not statistically significant, 
the Mann-Whitney U-test also determined that the number of cigarettes smoked per day (CPD) decreased 
by one-half from 20 to 10 (p= 0.069).  Fifty percent (50.0%) of participants reported participation in 
inpatient tobacco treatment that included pharmacological participation by the three-month follow-up, but 
very few smokers (n= 2; 7.4%) reported participation in behavioral tobacco treatment (Table 5). None of 
the high-risk, eligible smokers completed the recommended lung cancer screening via LDCT. 
 
 
Table 5. Smoking Characteristics of Participants at Enrollment (Post-TTS) and Three-Month Follow-up 
 
Participant Characteristics (N= 63) 
 
 
Total sample 
post-TTS 
(n= 134) 
 
Participants 
at 3-months  
(N= 63) 
p-value 
 
  
   
  M ± SD 
Median [IQR] 
n (%) 
M ± SD 
Median [IQR] 
n (%) 
 
Smoking Characteristics and Behaviors   
   
    Perceived Risk Scale Score (n= 61)  3.85 ± 1.05 3.57 ± 1.02 .193a 
    Readiness to Quit Score  6.98 ± 2.20 6.43 ± 2.46 .030a 
    Every Day or Some Days Smoker   134 (100%) 43 (68.3%) .587c 
    Quit Smoking (30-day point prevalence)  - 20 (31.7%) 
 
    Quit Attempt (n= 62)  9 (6.8%) 48 (77.4%) .264c 
    Cigarettes smoked per day among current smokers (n= 42)  20 [10 – 20] 10 [4 – 20] .069b 
    Significantly reduced CPD by ≥ 50% among all participants  - 40 (63.5%) 
 
Tobacco Treatment Services  
   
    Pharmacological Participation (n= 38)  - 19 (50.0%) 
 
    Quit Line Participation (n= 26)  - 2 (7.4%) 
 
    Lung Cancer Screening Participation (n= 11)  - 0 (0%) 
 
a Paired Samples T-test b Mann-Whitney cChi-Square Test of Independence  
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Bivariate Correlations between Perceived Risk and Smoking Risk Factors 
  
Previously identified correlates of smoking-related outcomes were examined in study subjects to 
assess their potential association with perceived risk for developing a smoking-related health condition. 
These contextual smoking risk factors included: readiness to quit (RTQ), time to first cigarette (TTFC), 
cigarettes per day (CPD), participant age, concurrent other tobacco use, comorbid smoking-related 
disease, subjective health literacy, household income below poverty level, and education. (See Appendix 
A for comprehensive correlation matrix of all study variables). The correlation analyses matrix was then 
simplified by only including statistically significant associations (Table 6). Table 6 reports the simple 
bivariate correlations of the included smoking risk factors with the two measures of perceived risk (pre-
TTS and post-TTTS) at study enrollment. Spearman’s rho bivariate correlations were used to evaluate the 
statistical dependence between the rankings of each pair of study variables. Bonferroni corrections (α= 
0.05/10 = 0.005) were applied to examine significant correlations between perceived risk and smoking 
risk factors measured at study enrollment.  
The inter-correlations among perceived risk and smoking risk factors provided evidence for 
concurrent and predictive validity. As expected, both perceived risk measures (pre-TTS and post-TTS) 
were significantly positively correlated with one another at the less than .001 significance level (ρ= -.61; 
p<.001), indicating that subjects reported comparable perceived risk scores before and after inpatient 
tobacco treatment. Additional statistically significant relationships included positive correlations between 
participant age with comorbid smoking-related disease (ρ= -.63; p<.001), where older participant age was 
associated with a diagnosis of more heart and lung conditions documented in the electronic medical 
record. Significantly negative inter-correlations were identified among the study variables as well. Post-
TTS perceived risk was inversely correlated with TTFC (ρ= -.31; p<.001), such that lower post-TTS 
perceived risk scores were associated with the subject waiting a longer duration of TTFC at study 
enrollment. Other significantly negative correlations were identified between CPD with both RTQ and 
TTFC (ρ= -.30; p<.001 and ρ= -.63; p<.001, respectively). These findings indicate the following 
relationships: higher number of CPD was associated with lower ratings of motivation to quit (RTQ) and a 
shorter duration of TTFC in the morning.  
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Table 6. Significant Bivariate Associations between Perceived Risk and Smoking Risk Factors  
at Study Enrollment 
Key Variables V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 V11 
V1 
Perceived Risk      
(pre-TTS, 
retrospective) 
- .61**          
V2 Perceived Risk     (post-TTS)  -  -.31**        
V3 Readiness to Quit   -  -.30**       
V4 Time to First Cigarette  -.31**  - -.46** 
      
V5 Cigarettes Per Day   -.30** -.46** -       
V6 Participant Age      -  .63**    
V7 Concurrent Other Tobacco Use 
      -     
V8 
Comorbid 
Smoking-Related 
Disease 
     .63**  -    
V9 Subjective Health Literacy 
        -   
V10 
Below the 
Household Income 
Poverty Level 
         -  
V11 Education Level         
(≥ HS) 
          - 
Note: n= 134; Spearman’s Rho correlations = <.005 (adjusted p-value) and <.001** 
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Results Related to Aims 
 
 
Results for Aim 1 
 
All study subjects (n= 134) were asked the following questions: “How likely are you to develop 
lung cancer”; “How likely are you to develop a smoking-related disease?”; “How likely are you to 
develop lung cancer”; and “How likely are you to develop a smoking-related disease compared to other 
people your age?” Responses to these four items were summed and a total ‘perceived risk’ score was 
calculated. Among all subjects (n=134), the mean pre-TTS score was 3.43 ± 1.05 (SD) and the post-TTS 
score was 3.80 ± 0.97 (SD).  Both scores fall between the neutral (‘neither likely nor unlikely’) and 
‘likely’ response choices. The pre to post-TTS change was 0.37 but was not statistically significant based 
on the RCI calculated for change in perceived risk. The reliable change index was 0.82, indicating a 
meaningful, clinically significant difference. Based upon the reliable change index, subjects were 
categorized into three categories (Table 7). Only 23.1% demonstrated a reliable change index greater than 
0.82, indicating an increase in perceived risk. 
         Since this is the first documented study in which these four items have been used as a proxy 
measure of ‘perceived risk,’ the internal consistency of all four items between the pre-TTS assessment 
and post-TTS assessment was determined using Cronbach’s alpha reliability analyses. It was 
demonstrated that the pre- and post-TTS four items had shared covariance and likely measure the same 
underlying construct of perceived risk among study respondents with a Cronbach's alpha coefficient of 
0.92, which demonstrated findings similar to previous studies. 
 
 
Table 7. Summary Statistics of Reliable Change in Perceived Risk among Hospitalized Smokers from 
Pre-TTS to Post-TTS (n=134) 
Reliable Change in Perceived Risk N % 
Reliable decrease 6 4.5 
None 97 72.4 
Reliable increase 31 23.1 
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Results for Aim 2 
 
The Readiness to Quit (RTQ) score was approximately 7 (6.98 ± 2.20) at study enrollment (and 
this score is assigned to the response: “I definitely plan to quit smoking in the next 30 days”). Because of 
the sample size, simple linear regressions were run to assess relationships between pre-TTS 
(retrospective) perceived risk and smoking risk factors, such as TTFC, CPD, participant age, concurrent 
other tobacco use, comorbid smoking-related disease, subjective health literacy, household income below 
poverty level, and education at study enrollment. Perceived risk was completely uncorrelated with 
readiness to quit. However, fewer CPD is associated with the likelihood of a higher RTQ score (β=-0.039, 
p<0.017) (Table 8). As such, the regression equation infers that a decrease of 10 CPD (e.g., a decrease 
from 20 to 10 CPD or 1 pack to ½ pack per day) is associated with an increase in the RTQ score of 0.39 
points (10 x 0.039). As the relationship is linear, the increase in RTQ applies to any number of CPD.  
 
 
Table 8. Simple Linear Regressions between Readiness to Quit after Inpatient Tobacco Treatment and 
Perceived Risk (pre-TTS) with Smoking Risk Factors (N= 134) 
Simple Linear Regressions Unstandardized 
Coefficient 
Standardized 
Coefficient 
 95% C.I 
Lower - Upper 
 
Sig. 
Variable B Std. Error Beta t    
Pre-TTS (retrospective) perceived risk -.113 .183 -.054 -.618 -.475 .249 .537 
Post-TTS Perceived Risk  -.037 .197 -.016 -.186 -.426 .353 .853 
Time to First Cigarette .010 .006 .150 1.733 -.001 .022 .086 
Cigarettes Per Day -.039 .016 -.205 -2.410 -.072 -.007 .017* 
Participant Age .016 .014 .099 1.148 -.011 .043 .253 
Comorbid smoking-related disease -.067 .089 -.065 -.752 -.243 .109 .454 
Subjective Health Literacy -.032 .057 -.049 -.553 -.145 .082 .582 
Concurrent Other Tobacco Use -.255 .548 -.041 -.465 -1.338 .828 .642 
Income Below Poverty Level -.708 .405 -.162 -1.750 -1.510 .094 .083 
Education ≥ High School -.642 .458 -.133 -1.403 -1.549 .265 .163 
*significant at <.01 
a. Readiness to quit is defined as a continuous variable 
 
 
A multiple linear regression analysis (Table 9) was performed to examine statistical significance 
between study predictor variables and RTQ to adjust for additional cofactors that could influence smoking 
behavior. A significance threshold of p< 0.1 was used to determine inclusion of smoking risk factors 
examined in the simple regression analyses for RTQ. Application of threshold guidelines permitted 
inclusion of the following three predictor variables: CPD, TTFC, and household income below the 
poverty level. Pre-TTS (retrospective) perceived risk was also included in the multivariate analysis as the 
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main predictor variable of interest. After adjustment, pre-TTS (retrospective) perceived risk, CPD. TTFC, 
and household income below the poverty level did not impact RTQ (R2= .055, p<0.181) based upon 
statistical significance (Table 9).  
 
 
Table 9. Multiple Linear Regressions between Readiness to Quit after Inpatient Tobacco Treatment and 
Perceived Risk (pre-TTS) with Smoking Risk Factors (N= 134) 
Multiple Linear Regressions Unstandardized 
Coefficient 
Standardized 
Coefficient 
  95% C.I 
Lower - Upper 
 
Sig. 
Variable B Std. Error Beta  t    
(Constant) 7.853 .966   8.126 5.938 9.769 .000 
Pre-TTS (retrospective) perceived risk -.046 .212 -.200  -.215 -.466 .375 .830 
Time to First Cigarette .002 .007 .034  .316 -.012 -.017 .753 
Cigarettes Per Day -.030 .020 -.158  -1.494 -.069 .010 .138 
Income Below Poverty Level -.534 .415 -.122  -1.286 -1.357 .289 .201 
a. Readiness to quit is defined as a continuous variable 
 
 
Results for Aim 3  
 
As noted above, 63 subjects (designated as ‘participants’) were included in the analyses for aim 3. 
Among these participants, smoking behavior variables or outcomes were examined such as smoking 
status, an attempt to quit smoking, reduced cigarette consumption and participation in inpatient tobacco 
treatment (either pharmacological or behavioral modalities). 
Smoking Status. To evaluate ‘smoking status’ participants were asked, “Do you now smoke 
cigarettes every day, some days, or not at all?” A total of 31.7% (n= 20) of participants reported not 
smoking at 3-month post-TTS intervention. Of the 43 participants who continued smoking at the three-
month follow-up, 31 (49.2%) participants continued to smoke every day and 12 (19.0%) reported 
smoking only some days. Participants who reported not smoking were slightly older (58 years vs. 51 
years) than non-quitters. Also, those who reported not smoking reported lower CPD (13 CPD vs. 17 CPD 
pre-TTS), and a TTFC of longer than 5 minutes at study enrollment (non-smokers= 61.9% vs. smokers= 
41.9%). There were no statistically significant differences between study enrollment and three-month 
follow-up in smoking risk factors (e.g., age, CPD, etc.) between those who reported not smoking and 
those who continued to smoke.  
Eleven univariate binomial logistic regression analyses were performed to estimate the likelihood, 
or odds ratio (OR) that a study participant would report not smoking after three-months at follow-up due 
to significant relationships between pre-TTS (retrospective) perceived risk in the context of smoking risk 
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factors at study enrollment (Table 10). Perceived risk was completely unrelated to smoking status at 
three-month follow-up. Of the smoking risk factors examined, TTFC (OR= 1.02, 95% CI 1.00-1.03, 
p=0.038) was found to statistically significant to influence smoking status (Table 10). Therefore, for each 
unit of increase in TTFC of the day the participant was 1.02 times more likely to be a non-smoker at the 
3-month follow-up. At study enrollment, the median time of TTFC for participants who did not smoke 
reported a median time of TTFC of 30.00 minutes and those who continued to smoke at follow-up 
reported a median TTFC of 5.00 minutes or less (Table 10). 
 
 
Table 10. Univariate Logistic Model Estimates of Perceived Risk and Smoking Risk Factors on Smoking 
Status at Three-Month Follow-Up (N= 62) 
Univariate Logistic Regressions   
 
OR 
95% C.I 
Lower - Upper 
 
p-value 
 Not Smoking at 3 months     
Variable No 
Median [IQR] 
n (%)  
Yes 
Median [IQR] 
n (%)  
    
Pre-TTS (retrospective) perceived risk 3.38 [2.50 - 4.00] 3.25 [3.00 - 4.00] 1.13 .68 1.90 .634 
Post-TTS Perceived Risk  4.00 [3.31 - 5.00] 3.75 [3.13 - 4.25] .69 .41 1.17 .170 
Readiness to Quit 7.00 [5.00 - 9.00 9.00 [7.00 - 9.00] 1.30 .99 1.70 .058 
Time to First Cigarette 5.00 [5.00 - 30.00] 30.00 [5.00 - 90.00] 1.02 1.00 1.03 .038* 
Cigarettes Per Day 16.50 [10.00 - 20.00] 10.00 [4.00 - 20.00] .96 .91 1.02 .202 
Participant Age 51.00 [44.50 - 60.25] 60.00 [51.50 - 66.00] 1.04 .10 1.09 .070 
Comorbid smoking-related disease 2.00 [.25 - 5.00] 3.00 [2.00 - 4.00] 1.10 .87 1.38 .439 
Subjective Health Literacy 13.50 [12.00 - 15.00] 14.00 [11.00 - 15.00] 1.07 .88 1.29 .518 
Concurrent Other Tobacco Use 8 (18.6%) 3 (14.3%) .72 .17 3.09 .668 
Income Below Poverty Level 19 (51.4%) 4 (25.0%) .31 .09 1.16 .083 
Education ≥ High School 26 (63.4%) 15 (75.0%) 1.73 .52 5.72 .368 
*significant at <.05 
a. Smoking Status is defined as a dichotomous variable (yes/no) 
b. Column percentages 
 
 
Self-Reported Quit Attempt. A self-reported quit attempt is a behavioral measure defined as 
whether or not the smoker abstained from smoking cigarettes for more than one day because they were 
trying to quit, between study enrollment study enrollment and three-month follow-up. Self-reported quit 
attempt was determined by a “yes” or “no” response to the following question, “During the past three 
months, did you quit smoking for more than one day because you were trying to quit?” At the three-
month follow-up, 77.4% (n= 48) of participants reported they had tried to stop smoking since study 
enrollment. 
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Eleven univariate binomial logistic regression analyses were performed to estimate the 
probability that a participant would make a quit attempt between study enrollment and three-month 
follow-up (Table 11). Perceived risk was completely unrelated to making a quit attempt between study 
enrollment and the three-month follow-up. Of the smoking risk factors examined, only RTQ at study 
enrollment (OR= 2.08, 95% CI 1.38-3.14, p<.001) was statistically significant and likely to influence a 
self-reported quit attempt. Therefore, participants were 2.08 times more likely to self-report a quit attempt 
at three months for each unit increase on the RTQ ladder. The median RTQ score for participants who did 
not attempt to quit was 5.00, which is associated with the response, “I often think about quitting smoking, 
but I have no plans to quit”. Participants that did attempt to quit, had a median score of 9.00 on the RTQ 
ladder which indicates “I have quit smoking, but I still worry about slipping back, so I need to keep 
working on living smoke free.” Perceived risk was completely unrelated to making a quit attempt between 
study enrollment and three-month follow-up.  
 
 
Table 11. Univariate Logistic Regression Analyses of Perceived Risk and Smoking Risk Factors on Self-
Reported Quit Attempt at Three-Month Follow-Up (N= 63) 
 
Univariate Logistic Regressions 
   
OR 
95% C.I 
Lower - Upper 
 
p-value 
 Quit Attempt at 3 months     
Variable No 
Median [IQR] 
n (%)  
Yes 
Median [IQR] 
n (%)  
    
Pre-TTS (retrospective) perceived risk 4.00 [2.75 - 4.56] 3.00 [2.81 - 4.00] .65 .35 1.22 .178 
Post-TTS Perceived Risk  4.13 [3.00 - 4.81] 4.00 [3.25 - 4.25] .78 .39 1.54 .474 
Readiness to Quit 5.00 [4.75 - 6.00] 9.00 [7.00 - 9.00] 2.08 1.38 3.14 < .001** 
Time to First Cigarette 30.00 [5.00 - 30.00] 5.00 [5.00 - 60.00] 1.01 .99 1.03 .487 
Cigarettes Per Day  10.00 [5.00 - 20.00] 10.00 [3.00 - 16.25] .98 .93 1.03 .455 
Participant Age 57.00 [42.50 - 66.50] 53.00 [46.25 - 63.00] 1.01 .96 1.05 .764 
Comorbid smoking-related disease 4.00 [.00 - 5.00] 3.00 [1.00 - 4.00] .94 .73 1.22 .636 
Subjective Health Literacy 14.5 [10.50 – 15.00] 13.00 [12.00 – 15.00] .97 .79 1.19 .768 
Concurrent Other Tobacco Use 2 (15.4%) 9 (18.8%) 1.27 .24 6.76 .780 
Income Below Poverty Level 3 (27.3%) 18 (45.0%) 2.18 .50 9.45 .297 
Education ≥ High School 9 (75.0%) 31 (66.0%) .65 .15 2.72 .552 
**significant at <.001 
a. Quit Attempt is defined as a dichotomous variable (yes/no) 
b. Column percentages 
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Reduced Cigarette Consumption. Another measure of smoking behavior was reduction in the 
number of cigarettes smoked per day (CPD) at the three-month follow-up assessment relative to the 
number of cigarettes smoked per day at study enrollment. Similar to other studies, a significant reduction 
in cigarette consumption was defined by a greater than or equal to 50% reduction in CPD, or ‘cut back’ 
between study enrollment and three-month follow-up (Hatsukami et al., 2005). Of the 63 participants, 
63.5% (n= 40) reported a significant reduction in cigarette consumption by greater than or equal to 50%. 
Participants who reported continuing smoking reduced cigarette consumption by approximately one-third 
less CPD by the three-month follow-up (e.g. study enrollment = 17 CPD vs. 3-months = 11 CPD). 
Eleven univariate binomial logistic regression analyses were performed to estimate the 
probability that a study participant would significantly lower their cigarette consumption between study 
enrollment and the three-month follow-up due to significant influence of pre-TTS (retrospective) 
perceived risk in the context of smoking risk factors at study enrollment (Table 12). Perceived risk was 
completely unrelated to reducing cigarette consumption by at least 50% at three-month follow-up, relative 
to study enrollment. Of the smoking risk factors examined, two were statistically significant to influence 
reduced consumption of CPD at three-month follow-up. Of the smoking risk factors examined, TTFC 
(OR= 1.02, 95% CI 1.00-1.05, p=0.033) and participant age (OR= 1.05, 95% CI 1.01-1.10, p=0.028) were 
found to statistically significant to influence reduced consumption of cigarettes (Table 12). Therefore, for 
each unit of increase in TTFC of the day the participant was 1.02 times more likely to lower cigarettes 
consumption by at least 50% at the 3-month follow-up. At study enrollment, the median time of TTFC for 
those who did not successfully ‘cut back’ at follow-up reported a median TTFC of 5.00 minutes or less 
while those who did ‘cut back’ reported a median time of TTFC of 30.00 minutes (Table 12). Also, for 
each year increase in age the participant was 1.05 times more likely to lower cigarettes consumption by at 
least 50% at the 3-month follow-up. The median age for those who did not successfully ‘cut back’ at 
follow-up was 49 years while those who did ‘cut back’ reported a median age of 58 years (Table 12). 
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Table 12. Univariate Logistic Regression Model Estimates of Perceived Risk and Smoking Risk Factors 
on Significant Reduction of Cigarette Consumption at Three-Month Follow-Up (n=63) 
 
Univariate Logistic Regressions 
   
OR 
95% C.I 
Lower - Upper p-value 
 Reduced CPD at 3 months     
Variable No 
Median [IQR] 
n (%)  
Yes 
Median [IQR] 
n (%)  
    
Pre-TTS (retrospective) perceived risk 3.50 [2.50 - 4.00] 3.13 [3.00 - 4.00] 1.07 .65 1.76 .788 
Post-TTS Perceived Risk  4.00 [3.00 - 4.50] 3.88 [3.25 - 5.00] .956 .54 1.67 .874 
Readiness to Quit  6.00 [5.00 - 9.00] 7.00 [6.00 - 8.00 1.20 .94 1.53 .146 
Time to First Cigarette 5.00 [5.00 - 30.00] 30.00 [5.00 - 60.00] 1.02 1.00 1.05 .033* 
Cigarettes Per Day  15.00 [10.00 - 20.00] 12.50 [6.25 - 20.00] 1.01 .98 1.10 .672 
Participant Age 49.00 [39.00 - 55.00] 58.00 [49.25 – 64.50] 1.05 1.01 1.10 .028* 
Comorbid smoking-related disease 2.00 [.00 - 4.00] 3.50 [1.00 – 4.25] 1.21 .95 1.54 .119 
Subjective Health Literacy 14.00 [12.00 - 15.00] 14.00 [11.00 - 15.00] 1.04 .87 1.23 .683 
Concurrent Other Tobacco Use 5 (22.7%) 6 (15.0%) .60 .16 2.25 .449 
Income Below Poverty Level 8 (42.1%) 14 (42.4%) 1.01 .32 3.18 .982 
Education ≥ High School 18 (81.8%) 22 (57.9%) .31 .09 1.08 .065 
***significant at <.05 
c. Significant Reduction is defined as a dichotomous variable (yes/no) 
d. Column percentages 
 
 
Participation in Inpatient Tobacco Treatment.  Participant smoking behaviors were also 
evaluated by assessing their participation in inpatient tobacco treatment. Participation was 
operationalized by evaluating participants’ acceptance of a recommendation for pharmacological tobacco 
treatment or referral for behavioral tobacco treatment via their state’s tobacco quit line and the subsequent 
use of the tobacco treatment modality. 
Among the 63 participants, 43 (68.25%) accepted TTS pharmacological tobacco treatment 
recommendations. Among those who accepted, 20 participants (46.5%) reported participation in 
pharmacological tobacco treatment using nicotine replacement and/or FDA-approved prescription 
medications. Eleven univariate binomial logistic regressions were performed to estimate the probability 
that a study participant would engage in pharmacological tobacco treatment between study enrollment 
and three-month follow-up (Table 13). No significant correlations were found between perceived risk, 
smoking risk factors, and participation in pharmacological tobacco treatment modalities. 
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Table 13. Univariate Logistic Regression Model Estimates of Perceived Risk and Smoking Risk Factors 
on Pharmacological Participation at Three-Month Follow-Up (n=38) 
 
Univariate Logistic Regressions 
   
OR 
95% C.I. 
Lower - Upper 
 
p-value 
 Pharmacology Use at Follow-Up     
Variable No 
Median [IQR] 
n (%)  
Yes 
Median [IQR] 
n (%)  
    
Pre-TTS (retrospective) perceived risk 4.00 [2.00 – 5.00] 3.00 [2.56 - 3.50] .78 .45 1.36 .376 
Post-TTS Perceived Risk  4.25 [2.50 - 5.00] 4.00 [3.50 - 4.94] 1.12 .62 2.02 .718 
Readiness to Quit 6.50 [5.00 -9.00] 7.00 [6.00 - 9.00] 1.21 .88 1.67 .244 
Time to First Cigarette 5.00 [5.00 -30.00] 5.00 [5.00 - 30.00] .98 .96 1.01 .255 
Cigarettes Per Day 20.00 [9.25 -26.25] 20.00 [10.00 - 20.00] 1.01 .95 1.07 .883 
Participant Age 54.00 [40.50 - 63.75] 49.00 [46.00 - 59.75] .99 .94 1.05 .778 
Comorbid smoking-related disease 1.50 [.00 - 6.00] 3.00 [1.25 - 4.00] .94 .71 1.26 .692 
Subjective Health Literacy 14.00 [11.50 - 15.00] 13.50 [11.25 - 14.75] 1.03 .81 1.30 .836 
Concurrent Other Tobacco Use 4 (22.2%) 4 (21.1%) .93 .20 4.47 .931 
Income Below Poverty Level 7 (50.0%) 10 (62.50%) 1.67 .39 7.15 .492 
Education ≥ High School 7 (41.2%) 11 (61.1%) 2.25 .58 8.69 .241 
a. Pharmacological Participation is defined as a dichotomous variable (yes/no) 
b. Column percentages 
 
 
Among the 63 participants, 26 (41.27%) accepted a TTS referral for behavioral tobacco 
treatment. Only 2 (3.2%) participants reported actual participation with State Tobacco Quit line (at least 
one session with a quit line counselor over the telephone) between study enrollment and the three-month 
follow-up. Due to a nearly complete lack of participation with the state tobacco quit line, a logistic 
regression model was not run to identify significant associations that increased the likelihood of a 
participants’ participation with behavioral tobacco treatment. 
 
 
Results for Aim 4  
 
Among all hospitalized smokers enrolled, 42 (65.6%) were eligible for LDCT imaging treatment 
between study enrollment and the three-month follow-up. However, 16 (38.1%) were not offered a 
referral due to a variety of potential obstacles that occur in the inpatient setting. Of the 11 (17.5%) 
participants that accepted the referral, none had completed the recommended imaging for lung cancer 
screening via LDCT by at three-month follow-up. No inferential data analysis procedures were indicated 
to perform due to a complete lack of participants reporting for this outcome variable. 
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Chapter V 
 
 
Discussion 
 
 
Summary of Findings 
 
This study provides new information by examining the change in perceived risk before and after 
tobacco treatment counseling and by exploring the influence of contextual smoking risk factors and 
perceived risk on smoking-related outcomes among adult, hospitalized smokers. Perceived risk was 
assessed in the study to understand the degree in which the smoker acknowledged their likelihood of 
developing a smoking-related health condition. Study procedures were unique in that perceived risk was 
measured twice at study enrollment to examine changes in risk perceptions that may occur after exposure 
to a brief, inpatient tobacco treatment program. The first determination of perceived risk was measured 
immediately following informed consent and after TTS exposure; this determination assessment was 
referred to as “post-TTS perceived risk”. The second determination of perceived risk, referred to as “pre-
TTS (retrospective) perceived risk” was measured next using an evaluation technique known as a 
retrospective pretest (Curtis & Drennan, 2013). 
The main study findings are: 1) A small, but positive change in perceived risk (as measured by a 
modified 4-item survey) was observed among 23% of hospitalized smokers after inpatient tobacco 
treatment; 2) Neither pre- nor post-TTS perceived risk statistically influenced readiness to quit at study 
enrollment or smoking behavior outcomes at three months; and 3) Risk factors found to positively 
influence smoking behavior outcomes at three-month follow-up were higher readiness to quit (RTQ) on a 
self-reported quit attempt and reporting education beyond high school on reduction on cigarettes per day 
(CPD) by at least 50%. TTFC (OR= 1.02, 95% CI 1.00-1.03, p=0.038) was found to statistically 
significant to influence smoking status. RTQ at study enrollment (OR= 2.08, 95% CI 1.38-3.14, p<.001) 
was statistically significant and likely to influence a self-reported quit attempt. TTFC (OR= 1.02, 95% CI 
1.00-1.05, p=0.033) and participant age (OR= 1.05, 95% CI 1.01-1.10, p=0.028) were found to 
statistically significant to influence reduced cigarette consumption.  
Study data did not support the independent influence of perceived risk or any smoking risk 
factors on key clinical services offered during inpatient tobacco treatment (pharmacological, behavioral, 
and lung cancer screening via LDCT). However, the prevalence of participant participation in positive 
smoking behaviors at three-month follow-up were notable after exposure to brief, inpatient tobacco 
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treatment from the VUMC TTS. This chapter discusses the major findings and presents study limitations 
and recommendations for future study. 
 
 
Characteristics of the Sample 
 
One hundred thirty-four (134) adult, hospitalized smokers (mean age of 50.03 ± 13.95) were 
recruited at study enrollment after exposure to inpatient tobacco treatment. The study sample of inpatient 
smokers was represented by equal gender groups and a higher percentage of White participants (77.6%; 
n= 104), which is typical of other smoking behavior studies. Also, the total sample, as exemplified by the 
variable ‘time to quit smoking’ (TTFC), was highly addicted to nicotine with 50.8% reporting a TTFC 
within five minutes upon waking, smoked approximately one pack of cigarettes per day (CPD) (median 
CPD= 20, IQR= 10 - 20), and self-reported experiencing a 30 pack-year smoking history (median 
reported; IQR= 16.25 – 49). Similar to the demographic profile of U.S. smokers, a large proportion of 
smokers in the study were considered to have low socioeconomic status (SES) (CDC, 2015). Compared to 
the prevalence among the U.S. population of smokers from lower-income communities (72%), 67.2% (n= 
88) were unemployed and 53.0% (n= 71) reported an annual household income below the poverty level 
(CDC, 2015). Data collection ended for each participant after completion of the three-month survey. 
Attrition rates at three-month follow-up (53.0%; n= 71) are comparable to or better than those of 
other studies examining smoking behaviors among adult smokers receiving tobacco treatment [~54% to 
59%] Belita & Sidani, 2015; Faseru et al., 2011; Kim et al., 2015; [4.5%–28.6%] Ylioja et al., 2017). 
Differential dropout by age, employment, income, comorbid smoking-related disease, acceptance of 
tobacco treatment recommendations while hospitalized and evidence of a comorbid smoking-related 
diagnosis was evident at follow-up. Based upon statistical significance, three-month responders were 
more likely to be older, employed, earning a household income above the poverty level, diagnosed with 
congestive heart failure, and less willing to accept pharmacological tobacco treatment for smoking 
cessation.  
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Discussion of Results by Study Aim 
 
 
Aim 1: Change in Perceived Risk before and after Inpatient Tobacco Treatment 
 
In this study, among adult, hospitalized smokers (mean pre-TTS (retrospective) perceived risk 
score of 3.43 ± 1.05), perceived risk for developing a smoking-related health condition increased by 
approximately one-third (+0.37) after exposure to a brief, inpatient tobacco treatment program. The 
average perceived risk scores in this study were similar to perceived risk scores (M= 3.50) reported 
among outpatient smokers described as “medically ill” and diagnosed with more than one smoking-
related health condition in previous investigations (Borrelli et al., 2010; Sinicrope et al., 2010). Despite an 
observed increase in perceived risk for developing a smoking-related health condition, statistical and 
clinically, meaningful change in perceived risk was determined by using a reliable change index (RCI). 
Results of the RCI found that a change in perceived risk was statistically significant if greater than or 
equal to ±0.82.  
Comparison of a retrospective, pre-test (pre-TTS) assessment of perceived risk with results of an 
assessment of perceived risk at study enrollment (post-TTS) indicated a statistically significant increase in 
perceived risk for developing a smoking-related health condition among 23% of all hospitalized smokers 
in the study. However, there is consensus among outpatient tobacco research studies that a clinically 
significant change in perceived risk corresponds with an observed difference of at least one unit on the 
five-point ordinal scale between measurements (e.g., movement from ‘likely’ to ‘very likely’) (Borrelli, 
Hayes, Dunsiger, & Fava, 2010; Bunge et al., 2008; Carere et al., 2015; Chena & Kaphingst, 2010; Harris 
et al., 2012; Shofer et al., 2014). Based upon this criterion, the increase (RCI= +0.82) in perceived risk 
observed among hospitalized smokers in the current study did not represent a significant clinical impact 
and minimizes the potential influence of perceived risk on short-term smoking-related outcomes. 
Moreover, the conclusion of a small clinical effect on change in perceived risk as a result of inpatient 
tobacco treatment could not be validated given the absence of similar hospital-based studies.  
 
 
Aim 2: Readiness to Quit (RTQ) at Study Enrollment 
 
Readiness to quit smoking has been identified as a major barrier to smoking cessation and 
previous findings from tobacco intervention studies suggest that hospitalized smokers may be more 
motivated to quit smoking due to instability of their current health status (Sciamanna et al., 2000). It was 
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hypothesized that pre-TTS (retrospective) perceived risk would influence RTQ at study enrollment, in the 
context of other smoking risk factors, such as sociodemographic variables and comorbid health 
conditions. RTQ was operationalized by a psychological measure, the RTQ Ladder (Abrahms et al., 
2003). The average “readiness” score among the total sample of hospitalized smokers was 6.98 (SD= 
2.20), which indicates motivation to stop smoking ‘in the next 30 days’. In a larger study with over 500 
inpatient smokers exposed to inpatient tobacco treatment, the average RTQ score was 7.90 (Faseru et al., 
2011). However, mandates that forbid smoking in hospitals may influence patients, who had not smoked 
a cigarette since admission, to consider themselves more motivated and empowered to quit smoking.  
Smoking risk factors that have predicted readiness to quit in other studies include older age, lower 
levels of nicotine dependence, and concurrent use of other tobacco products (Poghosyan, Sheldon, & 
Cooley, 2012; Richardson, Xiao, & Vallone, 2012). Yet, lower CPD was the only smoking risk factor to 
significantly increase the likelihood of being more motivated to quit among hospitalized smokers in the 
current study (β= 0.039, p<0.017). Potential reasons for statistically insignificant findings among 
perceived risk and other smoking risk factors for this study aim are that hospitalized smokers in the total 
sample were generally middle-aged, were highly addicted to nicotine, and reported a prevalence of less 
than 15% for concurrent use of other tobacco products at study enrollment. Moreover, the algorithms used 
in outpatient settings to determine a smoker’s level of readiness to quit smoking may not be appropriate 
for clinical use with inpatient smokers (Sciamanna et al., 2000).    
 
 
Aim 3: Smoking Behaviors at Three-Month Follow-up 
 
Smoking behavior outcomes were assessed three months after study enrollment. It was 
hypothesized that at three-month follow-up, a higher pre-TTS (retrospective) perceived risk, in the 
context of smoking risk factors, would increase the likelihood of the following smoking behaviors 
variables: 1) non-smoking status (30-day point prevalence smoking abstinence), 2) self-report of a ‘quit 
attempt’ between study enrollment and follow-up, 3) reduction in CPD by at least 50% (relative to the 
number of self-reported CPD at study enrollment), and 4) participation in inpatient tobacco treatment 
modalities (pharmacological and/or behavioral treatment via the state tobacco quit line). Among 
responding participants at three-month follow-up, 32% (n= 20) quit smoking, 77.4% (n= 48) self-reported 
an attempt to stop smoking, and 63.5% (n= 40) reduced the number of smoked CPD by at least 50%. 
Study results indicate that smoking status, making a ‘quit attempt’, and reduction in CPD were positively 
influenced by smoking risk factors in this study, but perceived risk was not associated with these 
outcomes. 
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Smoking Status. Predictors of smoking cessation and long-term abstinence in adults typically 
include TTFC within five minutes of waking (high nicotine dependence), older age, and readiness to quit 
(Ferguson et al., 2003; Grandes, Cortada, Arrazola, & Laka, 2003; Harris et al., 2004; Lando, Hennrikus, 
McCarty, & Vessey, 2003; MacKenzie, Pereira, & Mehler, 2004). Current study results provide some 
support of these expectations by identifying that a longer duration of TTFC at study enrollment 
significantly increased the likelihood of smoking cessation by self-report at three-month follow-up (OR= 
1.02, 95% CI 1.00-1.03, p=0.038). Although TTFC was the only statistically significant smoking risk 
factor associated with smoking status, readiness to quit (OR= 1.30, 95% CI .99-1.70, p=0.058), 
participant age (OR= 1.04, 95% CI 0.10-1.09, p=0.070), and poverty level (OR= 0.31, 95% CI 0.09-1.16, 
p=.083) also demonstrated potential relationships with smoking status at three-month follow-up.  
Self-Reported Quit Attempt. A self-reported quit attempt is a behavioral measure defined as 
whether or not the smoker abstained from smoking cigarettes for more than one day because they were 
trying to quit, between study enrollment study enrollment and three-month follow-up. Of the smoking 
risk factors examined, only RTQ at study enrollment (OR= 2.08, 95% CI 1.38-3.14, p<.001) was 
statistically significant and likely to influence a self-reported quit attempt at follow-up. RTQ has been 
positively associated with a higher number of quit attempts and more concern about future health risks 
related to smoking in the literature (Feng et al., 2010; Gibbons, McGovern, & Lando, 1991; Mathur & 
Singh, 2015). Higher perceived health risk has been correlated to greater likelihood of making a quit 
attempt, among smokers with adverse medical conditions in other studies (Borrelli et al., 2010). 
Unfortunately, perceived risk was unrelated to making a quit attempt in the current study at three-month 
follow-up (OR= 0.65, 95% CI 0.35-1.22, p=.178).  
Reduced Cigarette Consumption. There are many sociodemographic, behavioral, 
environmental, and health-related variables related to smoking behaviors and health outcomes. Two of the 
most widely accepted independent risk factors for poor smoking outcomes are time to first cigarette 
(TTFC) within 5 minutes of waking in the morning and advanced age (Lando, Hennrikus, McCarty, & 
Vessey, 2003; USDHHS, 2014). In the current study, smoking ‘significantly’ less CPD by at least 50% 
was less probable at the three-month follow-up if the participant reported a TTFC of 5 minutes of less at 
study enrollment (median TTFC: 5 minutes vs. 30 minutes) and if the participant was younger on age 
(median age: 49 years vs 58 years). These finding support evidence that TTFC, an indicator of nicotine 
dependence, is a significant risk factor to consider in relation to reduced cigarette consumption. These 
findings also indicate the older smokers are more likely to lower their cigarette consumption to possibly 
prevent inherent negative health consequences associated with smoking and aging (American Lung 
Association, 2015; USDHHS, 2014).  
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Participation in Inpatient Tobacco Treatment. Initiating pharmacological tobacco treatment 
while hospitalized increases quit rates by 50% and bedside counseling followed by telephone support for 
at least one month after discharge increases smoking cessation rates by 40% (Rigotti, Clair, Munafo, & 
Stead, 2012). Study participants readily accepted pharmacological and behavioral tobacco treatment at 
study enrollment. During exposure to inpatient tobacco treatment, the majority accepted 
recommendations for pharmacological tobacco treatment (acceptance = 70.7%) and behavioral counseling 
via the state tobacco quit line (acceptance = 53.5%). In addition, 50% of participants at three-month 
follow-up reported use of a recommended medication to stop smoking. However, evidence asserts that 
hospitalized smokers require continued support after inpatient tobacco treatment, both while in the 
hospital and after discharge, to significantly influence smoking outcomes (Rigotti, Clair, Munafo, & 
Stead, 2012). Smokers enrolled in this study were not contacted after discharge with the purpose of 
offering supplemental tobacco treatment intervention. As a result, short-term cessation rates may fall 
short of comparable short-term cessation rates with previous studies. There were no significant 
relationships identified among perceived risk and contextual smoking risk factors to influence 
pharmacological tobacco treatment. Also, the small sample available for participation in behavioral 
tobacco treatment (7.4%, n= 2) prevented an analysis of relationships with study predictor variables. Low 
rates of participation among smokers referred to state tobacco quit lines is a typical finding of smoking 
intervention studies (Faseru et al., 2011). 
 
 
Aim 4: Lung Cancer Screening via LDCT at Three-Month Follow-up 
 
Evidence indicates that perceived risk influences compliance with recommendations to complete 
lung cancer screening via LDCT in outpatient settings, but LDCT screening rates among hospitalized 
smokers has been less well studied (Borelli et al., 2010; Carere et al., 2015; IOM, 2012; Park et al., 2013; 
Waters, McQueen, & Cameron, 2014). It was hypothesized that the higher the pre-TTS (retrospective) 
perceived risk for developing smoking-related health condition at study enrollment and three-month 
follow-up, the greater the likelihood that the referral for lung cancer screening via LDCT would be 
accepted and LDCT would be completed when assessed at the three-month follow-up. Yet, none of the 11 
study participants who accepted the referral at study enrollment reported completion of LDCT imaging at 
the three-month follow-up. 
Descriptive data analyses indicate that LDCT referrals were offered inconsistently to older, high-
risk smokers who were eligible for the preventive lung cancer screening. Out of 42 eligible smokers, TTS 
tobacco treatment specialist did not offer referrals for lung cancer screening via LDCT to 38% (n= 16) 
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hospitalized smokers in the total study sample. It is possible that eligible smokers were not offered LDCT 
study enrollment due to obstacles related to the inpatient setting or issues discovered during the tobacco 
treatment consultation but not documented in the EMR. Moreover, there are other criteria for lung cancer 
screening including life expectancy and willingness to undergo surgery if an abnormality is found on 
LDCT that is not represented in the data but influenced the TTS specialist’s decision to not offer 
preventive services.  
This study cannot provide information about LDCT screening in hospitalized smokers because 
there was a complete lack of participation reported at three-month follow-up. It is possible that valuable 
associations or inferences could have been obtained from the data if the remaining eligible smokers were 
offered a referral for lung cancer screening via LDCT at study enrollment. However, other studies have 
found that participation is typically low (below 4%) among the very smokers who could benefit from 
early lung cancer screening via LDCT (CMSb, 2015; Jemal & Fedewa, 2017; Moyer, 2014). Hospitalized 
smokers in this study appeared to be more willing to accept a referral for LDCT than the general 
population, but participation rates were lower than expected.  
 
 
Implications for Research Methods and Design 
 
This study sought to explored health risk perceptions in 134 adult, hospitalized smokers after 
being exposed to a brief, inpatient tobacco treatment program and investigate the influence of perceived 
risk, in the context of smoking risk factors, on smoking-related outcomes. A descriptive, correlational 
research study design approach was utilized to conduct a non-experimental, single group, pretest-posttest, 
quantitative study. No prior tobacco-related investigation had been conducted to test the application of a 
theoretical to explore potential factors that cause variance in smoking behavior outcome variables (Finney 
et al., 2011; Griffin, Dunwoody, & Neuwirth, 1999). However, empirical evidence strongly supports the 
likely predictive influence of individual characteristics on the relationship between perceived risk for 
developing a smoking-related health condition and smoking-related outcomes, such as chronic disease 
severity, other co-morbid conditions, sociodemographic variables, and cultural factors (Benkert et al., 
2009; Borrelli et al., 2010; Jacobs et al., 2006; Musa et al., 2009; Persky et al., 2013; Saha et al., 2010; 
Shofer et al., 2014; Sinicrope et al., 2010). The current study was able to fill this research gap in tobacco 
literature and demonstrate the contextual influence of individual characteristics on smoking-related 
outcomes. Data collection procedures at study enrollment were completed during a face-to-face encounter 
at the bedside while the participant was hospitalized and a subsequent chart audit.  
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There were three major sources of methodological issues within the study: recruitment, 
measurement of perceived risk, and attrition/follow-up. Recruitment of eligible hospitalized smokers was 
limited by the availability of the PI to approach the patient within 48 hours of receiving an initial 
consultation for inpatient tobacco treatment. Recruitment rates of hospitalized smokers could have 
increased if it had been feasible to allow the TTS tobacco treatment specialist to recruit and/or obtain 
informed consent at the conclusion of their counseling session for inpatient tobacco treatment. 
Recruitment was also limited by patient availability during daytime hours when many were in lengthy 
consultations with hospital providers or out of their rooms for procedures.  
Perceived risk was consistently found to be an insignificant influence of smoking-related 
outcomes in the current study. The lack of significance could be related to measurement of the construct 
and/or measurement time periods. The measure of perceived risk for developing a smoking-related health 
condition used in the study produced an optimal Cronbach’s alpha of internal consistency reliability (α= 
0.92) comparable to other studies examining smokers. However, previous studies did not report reliability 
of perceived risk measurement in samples of hospitalized smokers. A 4-item survey was modified to 
assess perceived risk in the current study that included questions about concern about a smoker’s 
likelihood of developing both lung cancer and specific smoking-related health conditions such as heart 
and lung conditions. Further analyses of the 4-item measure may support suspicion that two constructs are 
represented according to health outcome (lung cancer vs. heart or lung disease). Also, measurement of a 
retrospective pretest for perceived risk may have introduced bias as a result of subject bias or social 
desirability (Pratt, McGuigan, & Katzev, 2000). Comparison of multiple measures of perceived risk 
among hospitalized smokers may provide significance for the observed change in risk perceptions after 
inpatient tobacco treatment. 
Completion of study aims was limited due to issues related to follow-up three-months after study 
enrollment. Attrition at the three-month follow-up assessment period significantly affected the ability to 
perform inferential statistical techniques to evaluate relationships among study variables. Attrition may 
also be a contributing factor for the small number of statistically significant findings, despite strong 
evidence of influence between predictor and outcomes variables in the literature. Data were collected over 
a six-month study period at study enrollment, one-month follow-up, and three-month follow-up; but 
follow-up data was only analyzed at three-months. Other studies investigating the effects of inpatient 
tobacco treatment interventions typically conducted follow-up assessments between six and twelve 
months (Rigotti, Clair, Munafo, & Stead, 2012). Extending the current study’s active period beyond 
three-months could have potentially produced more statistically significant or impactful long-term results 
related to smoking behavior outcomes. Providing financial incentives for study participation and follow-
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up is a more likely methodological modification that would improve follow-up and successful completion 
of study aims.  
A more comprehensive and aggressive pursuit to obtain follow-up communication by postal mail, 
in person, or over a longer period of time could have minimized attrition rates. In anticipation of the high 
attrition rates experienced in other small-scaled tobacco treatment studies, a concerted effort was made by 
the PI to establish rapport with study enrollees to encourage understanding of the study purpose. In 
addition, multiple communication channels were accessed to interact with study participants. At study 
enrollment, participants were asked to provide at least two (2) telephone numbers to call and/or send 
mobile messages, and they were asked to provide an electronic message (email) address, as well. It 
appears that lower socioeconomic status among study participants was a significant influence towards 
communication failure given that differential drop out was evident due to poverty level and many 
telephone numbers were no longer in working order at the time of study follow-up.  
 
 
Implications for Clinical Practice 
 
Inpatient tobacco treatment interventions can effectively promote smoking cessation and 
sustained abstinence after discharge from the hospital (CMSa, 2015; Faseru et al., 2011; Nahhas et al., 
2016; PHS, 2008; Reid et al., 2015; Rigotti et al., 2014; Rigotti, Munafo, & Stead, 2008). In this study, 
15% (intent to treat = 20/134) of smokers in the total sample of hospitalized smokers and 32% (n= 20) of 
hospitalized smokers at three-month follow-up self-reported cessation after exposure to TTS tobacco 
treatment services. Previous studies within a systematic review of inpatient tobacco cessation programs 
indicated that the estimated effect of a high-intensity inpatient tobacco treatment intervention is smoking 
cessation rates of 37% at six and 12 months after hospital discharge (Rigotti, Clair, Munafo, & Stead, 
2012). Inpatient tobacco treatment interventions of lower intensity have not been shown to be as effective 
(Rigotti, Clair, Munafo, & Stead, 2012). High-intensity interventions include multiple counseling sessions 
and supportive follow-up communication for at least one month after hospital discharge.  
Participants were exposed to a low-intensity inpatient tobacco treatment intervention with no 
established protocol to provide follow-up support. However, results indicate that smoking cessation rates 
among participants who responded after three months were comparable to cessation rates among 
hospitalized smokers in previous investigations (~32% to 37% at 6 to 12 months follow-up) (Faseru et al., 
2011; Rigotti, Clair, Munafo, & Stead, 2012). Results also indicate that 77.4% (n= 48) of responding 
participants at the three-month follow-up self-reported a quit attempt and 63.5% (n= 40) of participants 
reduced the number of smoked CPD by at least 50%. Brief communication between the PI and 
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participants during one and three-month follow-up assessments may have produced higher smoking 
cessation rates than what would have occurred if there were no follow-up communication at all. However, 
short-term cessation rates and long-term smoking abstinence would be more likely to occur had follow-up 
communication been facilitated by a tobacco treatment specialist.  
 
 
Limitations 
 
 
Sample Attrition 
 
No published data were available to prospectively estimate potential sample characteristics. This 
dearth of information about perceived risk among hospitalized smokers indicated a gap in the literature 
and the need for this research study but limited the ability to determine the target sample size needed to 
achieve 80% power. Therefore, an a priori power analysis and preliminary sample size estimation was 
conducted to overcome potential limitations that could affect interpretation of study findings (Shadish, 
Cook, & Campbell, 2002). The sample size of 134 adult, inpatient smokers recruited at study enrollment 
is small when compared to other multi-site, inpatient tobacco treatment intervention studies, which 
contained thousands of participants. A sample that is too small in size inhibits the ability to identify 
significant relationships from the data compared to what might result in the presence of a larger effect 
size (Radosevic, 2005). The massive attrition experienced during follow-up assessment at three-months 
removed any advantage gained from the priori power analysis. The influence of demographic and clinical 
factors on attrition has been inconsistent across tobacco treatment intervention studies. However, results 
for differential drop in this study out are typical. 
 
 
Data Collection 
 
Data confirmation by self-report was the only practical method to assess the subjective and 
behavioral variables examined in this study. As a result, participants may have underestimated, 
exaggerated, or purposefully misreported responses concerning their smoking behaviors. Despite inherent 
limitations associated with using self-reported data, self-reported smoking cessation has been 
biochemically verified in other studies. Biochemical testing to determine smoking status, such as the 
measurement of exhaled carbon monoxide, was not feasible to acquire in this study due to financial 
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constraints. However, other studies report that self-reported CPD has been biochemically verified against 
measurement of exhaled carbon dioxide levels and urinary cotinine, the “gold standard” (Hennrikus et al., 
2005; Rigotti et al., 1997; Studts et al., 2006).  
 
 
Statistical Analyses  
 
The statistical procedures chosen to evaluate study findings were limited largely to descriptive 
and univariate inferential techniques. An attempt to interpret inferential relationships using data from this 
study may be subject to error because of confounding variables and validity threats such as history, 
maturation, test effects and regression to the mean (Cook & Campbell, 1979; Shadish, Cook, & 
Campbell, 2002). Missing data due to attrition significantly reduced statistical power to assess outcome 
variables with advanced statistical analyses. Thus, descriptive relationships were evaluated between study 
variables by identifying statistically significant associations and differences between participation groups. 
Missing data were also prevalent in the study due to missed opportunities by participants to engage with 
quit line counseling and missed opportunities by TTS tobacco treatment specialists to offer lung cancer 
screening via LDCT to eligible smokers.  
 
 
Implications for Future Research 
 
Clinically relevant knowledge and beliefs about smoking are associated with cessation and 
intention to quit (Carosella, Ossip-Kline, Watt, & Podgorski, 2002; Cummings et al., 2004; Dillard, 
McCaul, & Klein, 2006; Kerr, Watson, Tolson, Lough, & Brown, 2006; Tanni et al, 2017). Yet, perceived 
risk for developing a smoking-related disease risk was not found to have any statistically significant 
influence on any of the study outcome variables among smokers who were exposed to inpatient tobacco 
treatment. Regardless, significant bivariate associations demonstrate evidence that perceived risk remains 
an important concept to consider when assessing smoking-related outcomes among hospitalized smokers. 
Moderate association were noted between post-TTS perceived risk and time to first cigarette (ρ= -0.31; 
p<.001) and pharmacological tobacco treatment (ρ= 0.30; p=.001). These findings indicate that higher 
perceived risk scores after exposure to inpatient tobacco treatment may be associated with less TTFC 
(more nicotine addiction) and accepting a recommendation for pharmacological tobacco treatment.  
Limitations imposed by the lack of a comparison sample population eliminated the ability to 
make a statement about the generalizability of study outcomes or implications of effect size. However, 
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self-reported rates of engagement in positive smoking behaviors at three-month follow-up may suggest 
that inpatient tobacco treatment may influence perceived risk in a more impactful way with a larger 
sample of hospitalized, adult smokers. Low health literacy may serve as a critical and independent risk 
factor for poor cessation outcomes among low-socioeconomic status, racially/ethnically diverse smokers 
(Stewart et al., 2013). Higher subjective health literacy scores among this sample of adult, hospitalized 
smokers was unexpected given the level of nicotine addiction (median score: 13.0 [10 – 15]). However, 
the fact that most participants considered themselves capable of accessing, understanding and using basic 
health knowledge may have further contributed to positive smoking behaviors reported at three-month 
follow-up. 
Further analyses of this study’s data set would be valuable to identify characteristics associated 
with a clinically, meaningful reliable change in perceived risk based on group mean scores and those 
associated with clinically relevant change in perceived risk by at least one unit on the ordinal 
measurement scale based on general consensus (Borrelli, Hayes, Dunsiger, & Fava, 2010; Bunge et al., 
2008; Carere et al., 2015; Chena & Kaphingst, 2010; Harris et al., 2012; Shofer et al., 2014). This future 
research study would be enhanced with a larger sample of hospitalized smokers in order to apply 
perceived risk and all contextual smoking risk factors simultaneously in a regression model.  
Similar to the demographic profile of U.S. smokers, a large proportion of smokers in the study 
were considered to have low socioeconomic status (CDC, 2015). Compared to the prevalence of lower-
income smokers among the U.S. population (72%), 67.2% (n= 88) of hospitalized smokers in the study 
were unemployed and 53.0% (n= 71) reported an annual household income below the poverty level 
(CDC, 2015). In the current study, an annual household income level below poverty was statistically 
associated with several study variables. There was a significant, positive correlation between poverty and 
CPD (ρ= 0.23, p=<.05); while poverty was inversely correlated with TTFC (ρ= -0.19, p=<.05), education 
(ρ= -0.24, p=<.05), and age (ρ= -0.23, p=<.05). Finally, there was also a significant, inverse relationship 
between age and concurrent use of other tobacco products (ρ= -0.17, p=<.05) among hospitalized smokers 
in the study; and concurrent use is likely to impede smoking cessation efforts. Furthermore, results from 
the current study and previous studies indicate that socioeconomic status smoking risk factors (e.g., 
unemployment, household income below the poverty level, etc.) among study participants have the 
potential to significantly influence RTQ, smoking status, making a quit attempt, reduction in CPD, and 
attrition (at follow-up) among hospitalized smokers (Fagan et al., 2004; Morgan, Backinger, & Leischow, 
2007). Although the study sample was relatively small, consensus of study findings suggest support for 
generalizability of findings. 
Two conclusions were made to apply to promote further investigation of socioeconomic status 
and hospitalized smokers. Future studies are needed with larger, more diverse populations and 
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prospective designs to further validate these findings and the impact of socioeconomic status and age on 
perceived risk, smoking behaviors, and inpatient tobacco treatment outcomes (Brewer et al., 2007; Song 
et al., 2009). A new study aim would hypothesize that inpatient tobacco treatment would be more 
effective if an approach to treatment was identified that could remove the effect of significant 
sociodemographic disparities related to socioeconomic status and age. Also, financial incentives for 
follow-up could potentially combat attrition and promote the acquisition of sample sizes large enough to 
compare measures of internal reliability and reliable change with a similar sample population. 
Future research may also be enhanced with further in-depth analysis among groups of study 
participants based upon sociodemographic, smoking characteristics, and comorbid conditions 
(specifically, cardiopulmonary smoking-related diseases). There were several instances identified with 
descriptive statistical analyses where study enrollment characteristics were not congruent with factors that 
have been typically present when statistically significant predictions of smoking behaviors were made in 
previous studies. For example, readiness to quit is typically predicted to be higher among smokers who 
are of an older age, admitted to the hospital with a respiratory condition, report lower levels of nicotine 
dependence, and concurrently consume other tobacco products (Poghosyan, Sheldon, & Cooley, 2012; 
Richardson, Xiao, & Vallone, 2012; Shofer et al., 2014). Hospitalized smokers in this study were highly 
addicted to nicotine, as indicated by a smoking a pack of CPD on average and reporting a TTFC from five 
(5) to 30 minutes in the morning. Because one cannot conclude if the concepts and/or measures used in 
this study are useful in this population of hospitalized smokers, additional analysis among groups of 
hospitalized smokers at study enrollment and follow-up could also potentially predict attrition and various 
other smoking-related outcomes. These findings can be applied to enhance the recruitment plan of another 
study examining hospitalized smokers and estimate retention rates at follow-up.  
Most smokers fail to acknowledge the short- and long-term effects of smoking that will 
negatively affect their quality of life (Finney Rutten et al., 2008; Montes et al., 2007; Onken et al., 2005). 
However, the hospitalized smokers in this study reported a moderately elevated awareness of their 
individual smoking-related health risks even before being exposed to the tobacco treatment intervention. 
Then, there was a small, but positive increase observed from pre-TTS to post-TTS perceived risk scores. 
When compared to outpatient smokers, hospitalized smokers not actively seeking tobacco treatment may 
be more willing to accept expert advice and quit smoking in order to promote medical recovery (Brewer 
et al., 2007; CMS, 2015; Fiore et al., 2008; Oltedal, Moen, Klempe, & Rundmo, 2004; Reid et al., 2015; 
Rigotti et al., 2014). Although hospitalized smokers in the study permitted TTS services, only 23% of 
hospitalized smokers reported a ‘statistically significant’ reliable increase in perceived risk.  
As previously described, RCIs provide a supplemental means of analysis to comparisons of group 
means in outcome research with preventive interventions (Jacobson, Follette, & Revenstorf, 1984; 
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Jacobson & Truax, 1991). This study promotes new knowledge related to how measurement of a RCI can 
be used to evaluate clinically, significant aggregate change in risk perception related to smoking-related 
disease and lung cancer among hospitalized smokers. Unfortunately, the majority of the sample (72%, n= 
97) reported no statistically significant change (RCI = < ±0.82).  However, RCI may not need to be relied 
on as a sole measure of significance for the observed change in risk perceptions, given the observed, 
positive quitting behaviors among participants. Additional analyses of RCI scores could identify how 
many of hospitalized smokers experience a “ceiling effect” due to highly rated pre-TTS (retrospective) 
perceived risk scores and variables associated with reliable change. Medium to higher levels of perceived 
risk are expected among smokers diagnosed with hypertension (Borrelli et al., 2010) and older, high-risk 
smokers (Sinicrope et al., 2010). Almost 60% of the hospitalized smokers in this study had been 
diagnosed with hypertension, which may have contributed to the somewhat elevated pre-TTS 
(retrospective) perceived risk scores detected in this study. Data should be tested to understand if smokers 
with hypertension and other prevalent smoking-related diseases have higher perceived risk scores than 
those without disease.  
 
 
Conclusions and Next Steps 
 
No study to date had investigated the direct influence of perceived risk associated with smoking-
related health condition among hospitalized smokers. In the current study, perceived risk was not found to 
have significant influence over any smoking-related outcomes. Regardless, significant bivariate 
associations between perceived risk and smoking risk factors demonstrate evidence that perceived risk 
remains an important concept to consider when examining smoking-related outcomes in hospitalized 
smokers. Study findings also demonstrate how exposure to a brief, inpatient tobacco treatment program 
can positively impact smoking intentions and short-term smoking behaviors.  
Future investigation is warranted to continue exploration of health risk perceptions among 
hospitalized smokers to further elucidate relationships with contextual smoking risk factors and behavior 
outcomes in the following ways: 1) Further exploration of actual risks associated with specific adverse 
health conditions and cardiopulmonary smoking-related diseases may improve understanding of the 
perceptions of risk; 2) A secondary analysis of the data to evaluate group differences based upon the 
influence of nicotine dependence (e.g., CPD, TTFC) and socioeconomic status (e.g., employment status, 
educational attainment, household income below poverty, etc.) may provide a more reliable 
understanding of long-term smoking behaviors (CDC, 2018; Prochaska, Hall, Delucci, & Hall, 2014; 
Rigotti, Clair, Munafo, & Stead, 2012); 3) Item analyses (or other psychometric methods) of the 
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modified, 4-item measure of perceived risk in this study may detect cause to reduce the item count and 
retest the measure for reliability.  
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Appendix A. Additional Tables and Figures 
 
 
Risk Perception Intervention Studies
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Appendix B. Vanderbilt University Medical Center Tobacco Treatment Service Care Processes. 
VUMC TTS Care Protocol  
 
 
 
 
 
 
 
 
 
 
             
             
             
             
             
             
             
             
             
             
             
             
     
 
 
 
 
 
  
Delivery of an opt-out Evidence-based Inpatient TTS Consultation 
The Certified Tobacco Treatment Specialists approach smokers at the bedside and 
deliver the following services: 
Brief Motivational Interview 
Resolve barriers to abstinence  
Discuss previous attempts to quit/prevent future relapse 
Make plans to quit smoking 
Support previous success adopting cessation behaviors 
 
In-depth Historical Assessment 
Tobacco use and cessation history 
Barriers and motivation to quit smoking 
Lifetime smoking history by pack years 
 
 
TTS Documentation and Referral Completion 
Complete documentation of encounter and forward summary and quit plans to PCP 
If recommendation was accepted, prescribe or consult admitting MD to initiate pharmacotherapy 
If offer for State Tobacco Quit line was accepted, complete referral  
If offer was accepted to Lung Cancer Screening Clinic, complete referral  
 
Offer e-Referral to State Tobacco Quit line
Personalized feedback and advice for smoking cessation 
Out-patient counselors contact patient after discharge 
Recommend Pharmacotherapy 
Prescribe FDA-approved medications for smoking 
cessation, unless contraindicated 
Distribute Personalized, Written Material 
TTS brochure describing health effects of smoking 
Condition-specific patient education handouts  
Listing of community resources 
Offer referral to Lung Cancer Screening Clinic to eligible smokers 
Older, heavy smokers are eligible according to CMS criteria (55-77 
years old with a ≥30 pack year lifetime smoking history)  
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VUMC TTS Descriptions 
 
Historical Assessment. The historical assessment is performed to collect in-depth information 
about cigarette smoking and other tobacco use, including when smoking was initiated or how soon the 
first cigarette of the day is smoked after waking. Any previous cessation attempts are explored to discover 
how and why that decision was made and what prompted a relapse in smoking. Lifetime smoking history 
is calculated in pack years to summarize how the amount they smoke has changed over time. The smoker 
is asked to summarize their smoking history by quantifying up to three time periods of different daily 
smoking amounts. The specified number of cigarettes smoked each day and the corresponding number of 
years is entered into an algorithm table in StarPanel. The TTS StarForm computes individual pack years 
for each of the three time periods and then displays a value representing total pack years (by multiplying 
the average number of packs of cigarettes smoked per day by the number of years a person has smoked). 
Motivational Interview. A brief motivational interview is conducted to identify barriers to 
smoking abstinence and facilitate plans to quit smoking by implementing psychological and behavioral 
techniques (e.g set quit date, delaying the time to light up after waking). Plans to quit, motivation to quit, 
confidence in quitting, and previous quit attempts are explored to encourage smoking cessation. Other 
questions are asked to uncover any underlying psychological conditions, such as anxiety or depression 
that may be impeding cessation. The smoker is interrogated to preemptively recognize triggers for 
smoking and suggest alternative behaviors to avoid smoking in those instances. These strategies are 
reinforced by discussing and celebrating previous success with adopting smoking cessation behaviors and 
encouraging the use of post-discharge resources to prevent future relapse.  
Pharmacotherapy. The Tobacco Treatment Specialist recommends pharmacotherapy while 
considering contraindications utilizing the Vanderbilt Tobacco Control Order Set which features all seven 
FDA-approved medications to treat tobacco dependence. This order set was created for a similar tobacco 
treatment service in western Pennsylvania, and has been further updated to reflect the most recent 
evidence (Tindle, 2015). Options include: nicotine-replacement therapy (NRT) using a patch, gum, nasal 
spray, lozenge or inhaler or oral medications using Bupropion (Wellbutrin) or Varenicline (Chantix). 
National guidelines currently recommend initiating either combination therapy which combines two 
forms of nicotine replacement therapy (NRT) or Varenicline (Chantix) to improve the success of long-
term smoking cessation. Moreover, use of a long-acting NRT (patch) with a short-acting NRT (gum, nasal 
spray, lozenge or inhaler) can effectively control withdrawal symptoms, enhance comfort, and increase 
efficacy for long-term cessation (Tindle, 2015).  
The TTS StarForm contains protocols to guide dose and frequency decision-making. NRT 
pharmacotherapy may not be recommended or prescribed if the smoker is experiencing complications 
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with heart disease or abnormal heart rhythms or has been diagnosed with malignant hypertension or 
seizures. Oral medications may not be recommended or prescribed if there is evidence of substance abuse 
or poor adherence to current their medication regimen according to documentation in StarPanel. If 
eligible and interested, smokers can initiate the medication while hospitalized and receive a 30-day supply 
of one or more of the FDA-approved medications at discharge. In some cases, the Tobacco Treatment 
Specialist will recommend for the medication to be prescribed by the patient’s primary care doctor after 
assessing benefits versus risks for pharmacotherapy based on the smoker’s medical condition. The smoker 
has the option to either accept or decline pharmacotherapy recommendations. 
State Tobacco Quit line. All smokers are offered a referral to the quit line of their respective state 
to receive additional behavioral counseling after hospital discharge. The bi-directional referral is 
completed electronically through the Information and Quality Healthcare (IQH) Portal for tobacco 
treatment services and once complete allows quit line counselors to contact the patient directly within two 
days of hospital discharge. The quit line in Tennessee and surrounding states offer five telephone sessions 
of behavioral counseling over three months for smokers who are ready to quit or have recently quit. Those 
who engage with the quit line often achieve better long-term smoking behavior outcomes and counselors 
encourage smokers to follow-up with their primary care doctor to obtain medications, if pharmacotherapy 
had not already been initiated. The smoker has the option to engage in or not engage in quit line 
recommendations. 
Written Materials. The smoker is given personalized, written materials that include a brochure 
and other educational handouts. The VUMC TTS brochure reinforces education of the impact of smoking 
on health and general benefits of cessation. Disease-specific handouts are presented to educate the smoker 
about how smoking may exacerbate the medical conditions they are diagnosed with (e.g. hypertension, 
diabetes, or erectile dysfunction). Finally, a detailed compilation of contact information for community 
resources in the Nashville area is provided to smokers along with post-discharge other resources to 
support cessation.  
Lung Cancer Screening. Smokers are eligible to receive free lung cancer screening according to 
their actual risk for lung cancer by pack years. If the number of total pack years is ≥30 (high risk) and the 
smoker is between 55 and 77 years old, the smoker will be informed that they are at increased risk for 
developing lung cancer and will be referred to the LCS clinic (later in the consultation). The smoker has 
the option accept or decline the referral. If the number of total pack years is ≤29 (low risk) or the 
smoker’s age is <55 years, StarPanel will not confirm elevated risk for lung cancer and no risk 
communication or referral is provided. LDCT screening results are typically classified as “positive” to 
indicate a diagnosis for lung cancer, “abnormal,” or “indeterminate” to indicate the scan was concerning, 
or “negative,” or “normal” to indicate no concern for lung cancer. A “normal” result may not exclude the 
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presence of other non-lung cancer abnormalities, such as chronic obstructive pulmonary disease (COPD), 
interstitial lung disease, coronary artery calcification, or malignancy outside of the lungs (Kim et al., 
2014; Christensen & Chiles, 2015).  
A unique feature of the VUMC TTS protocol is offering a referral to obtain lung cancer screening 
via a LDCT. Older, heavy intensity smokers are eligible for a LDCT referral for lung cancer prevention if 
they are aged 55 to 77 years old and report a smoking history of ≥30 pack years. Referrals are directed to 
the Vanderbilt Lung Cancer Screening (LCS) Clinic, a recently established specialty clinic affiliated with 
the Vanderbilt-Ingram Cancer Center. It is managed by radiologist and clinical researcher, John Jeffrey 
Carr, MD along with Kim Sandler, MD, who oversees the development of the “Lung Cancer Screening 
Dashboard” in StarPanel that populates when a TTS smoker agrees to be referred for LCS (located in Star 
Panel on the left side under the Red Heading Dashboards, sub-heading Ancillary Dashboard, called Lung 
Cancer). The following information/columns related to the patient are also provided: action (allows to 
remove patient) MRN, patient name, actions, DOB, total pack years, how long since last smoked, and 
indicator for lung CT exam present on chart already. An LCS Clinic nurse coordinator will access the 
populated list, contact the patient’s primary care provider on file to inform them of their patient’s 
eligibility per CMS guidelines for lung cancer screening, discuss benefits versus risks for screening, and, 
if indicated, request an order for LDCT imaging. Upon receipt of an order for the LDCT scan, the nurse 
coordinator will contact the patient to schedule an appointment for consultation at the Vanderbilt LCS 
Clinic at One Hundred Oaks or one of several satellite locations.  
At the LCS Clinic initial consultative visit, a mid-level provider (e.g. nurse practitioner) will 
perform an evaluation to confirm eligibility for screening based upon CMS beneficiary eligibility criteria 
and provide additional tobacco treatment counseling for current smokers. The mid-level provider also 
engages the patient in shared decision making counseling (includes full disclosure about the benefits and 
harms of lung cancer prevention screening, the potential for follow-up diagnostic testing, prevalence of 
over-diagnosis and false positive rates, and total radiation exposure) to decide if they desire to proceed 
with LDCT screening. Patients under care at the LCS Clinic are also counseled about the importance of 
adherence to annual lung screening via LCDT, the chance of identifying co-morbidities during the scan, 
and factors that may impact diagnosis and treatment. Results of the CT scan are delivered to each 
patient’s primary care provider for review and may be electronically released for patient review in My 
Vanderbilt Health. Those who complete initial LDCT screening will be offered repeated annual scans and 
followed over three to five years. 
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